Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of outstanding shares of the registrant’s exchangeable shares, no par value, was 9,111,801 as of November 4, 2022.

The number of outstanding shares of the registrant’s common stock, par value $0.001 per share, was ~~21,607,633~~12,768,987 as of ~~May 9,~~November 4, 2022.

	March 31,			December 31,			September 30,			December 31,
	2022			2021			2022			2021
	(unaudited)						(unaudited)
ASSETS
Current assets
Cash and cash equivalents	$	3,791		$	5,893		$	2,852		$	5,893
Short-term investments		5,993			9,267			1,071			9,267
Accounts receivable, net		2,106			2,436			1,636			2,436
Inventories		4,521			3,824			5,271			3,824
Tax credits and receivables		1,117			1,099			1,076			1,099
Deferred cost of net revenue								600			—
Prepaid expenses and other		1,333			1,159			918			1,159
Total current assets		18,861			23,678			13,424			23,678

Long-term investments		2,399			2,928			—			2,928
Property and equipment, net		2,042			2,349			2,058			2,349
Intangible assets, net		7,852			8,355			6,803			8,355
Goodwill		9,946			9,946			9,946			9,946
Right-of-use lease asset, net		770			617			1,181			617
Other		78			78			129			78
Total assets	$	41,948		$	47,951		$	33,541		$	47,951

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	$	1,941		$	1,937		$	1,744		$	1,937
Accrued expenses and other		2,373			2,903			1,867			2,903
Deferred revenue		361			375			219			375
Short-term lease liability		422			379			633			379
Total current liabilities		5,097			5,594			4,463	��		5,594

Long-term lease liability		411			288			554			288
Total liabilities		5,508			5,882			5,017			5,882

Commitments and contingencies (Note 5)
Commitments and contingencies (Note 6)
Stockholders’ equity
Preferred stock, $0.01 par value; 20,000 shares authorized; NaN issued and outstanding		—			—
Common stock, $0.001 par value; 120,000 shares authorized; 21,588 shares and 21,579 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively		22			22
Preferred stock, $0.01 par value; 20,000 shares authorized								—			—
Series A special voting preferred stock, $0.01 par value; one share authorized; and one share issued and outstanding at September 30, 2022 and December 31, 2021, respectively								—			—
Common stock, $0.001 par value; 120,000 shares authorized; 12,757 shares and 12,284 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively								13			12
Exchangeable shares, no par value; unlimited shares authorized; 9,112 shares and 9,295 shares outstanding at September 30, 2022 and December 31, 2021, respectively								—			—
Additional paid-in capital		160,408			159,246			163,551			159,256
Accumulated other comprehensive loss		(37	)		—			(36	)		—
Accumulated deficit		(123,953	)		(117,199	)		(135,004	)		(117,199	)
Total stockholders’ equity		36,440			42,069			28,524			42,069
Total liabilities and stockholders’ equity	$	41,948		$	47,951		$	33,541		$	47,951

The accompanying notes are an integral part of these condensed consolidated financial statements.

	Three Months Ended						Three Months Ended						Nine Months Ended
	March 31,						September 30,						September 30,
	2022			2021			2022			2021			2022			2021
Net revenue
Product	$	3,204		$	1,051		$	3,060		$	1,389		$	10,384		$	3,016
Royalty and other		199			50			234			629			597			800
Total net revenue		3,403			1,101			3,294			2,018			10,981			3,816
Cost of net revenue		1,590			619			2,000			919			6,747			1,973
Gross profit		1,813			482			1,294			1,099			4,234			1,843
Operating expenses
Research and development		6,003			2,787			4,509			2,696			15,636			8,375
Selling, general and administrative		2,546			1,307			3,353			1,746			8,938			4,852
Gain on license and asset sale								(2,557	)		—			(2,557	)		—
Total operating expenses		8,549			4,094			5,305			4,442			22,017			13,227
Loss from operations		(6,736	)		(3,612	)		(4,011	)		(3,343	)		(17,783	)		(11,384	)
Interest expense		—			(513	)		(5	)		(870	)		(11	)		(2,170	)
Other expense, net		(18	)		(32	)		8			392			(11	)		147
Net loss	$	(6,754	)	$	(4,157	)	$	(4,008	)	$	(3,821	)	$	(17,805	)	$	(13,407	)

Other comprehensive loss, net of tax:
Net unrealized loss on available-for-sale securities		(37	)		—
Net unrealized gain (loss) on available-for-sale securities								5			—			(36	)		—
Comprehensive loss	$	(6,791	)	$	(4,157	)	$	(4,003	)	$	(3,821	)	$	(17,841	)	$	(13,407	)


Net loss per share
Basic and diluted	$	(0.34	)	$	(0.79	)	$	(0.20	)	$	(0.73	)	$	(0.89	)	$	(2.55	)
Shares used in computing net loss per share
Basic and diluted		19,769			5,241			20,039			5,258			19,950			5,250

The accompanying notes are an integral part of these condensed consolidated financial statements.

								Accumulated
					Additional			Other									Series A Special Voting													Additional			Accumulated Other
	Common Stock				Paid-In			Comprehensive			Accumulated						Common Stock				Common Stock				Exchangeable Shares					Paid-In			Comprehensive			Accumulated
	Shares		Amount		Capital			Loss			Deficit			Total			Shares		Amount		Shares		Amount		Shares			Amount		Capital			Loss			Deficit			Total
Balance as of December 31, 2021		21,579	$	22	$	159,246		$	—		$	(117,199	)	$	42,069			—	$	—		12,284	$	12		9,295		$	—	$	159,256		$	—		$	(117,199	)	$	42,069
Exchange of exchangeable shares																		—		—		100		—		(100	)		—		—			—			—			—
Issuance of common stock under stock plan, net		9		—		(9	)		—			—			(9	)		—		—		9		—		—			—		(9	)		—			—			(9	)
Stock-based compensation		—		—		1,171			—			—			1,171			—		—		—		—		—			—		1,171			—			—			1,171
Unrealized loss on available-for-sale securities		—		—		—			(37	)		—			(37	)		—		—		—		—		—			—		—			(37	)		—			(37	)
Net loss		—		—		—			—			(6,754	)		(6,754	)		—		—		—		—		—			—		—			—			(6,754	)		(6,754	)
Balance as of March 31, 2022		21,588	$	22	$	160,408		$	(37	)	$	(123,953	)	$	36,440			—		—		12,393		12		9,195			—		160,418			(37	)		(123,953	)		36,440
Issuance of common stock under stock plan, net																		—		—		244		1		—			—		(51	)		—			—			(50	)
Stock-based compensation																		—		—		—		—		—			—		1,738			—			—			1,738
Unrealized loss on available-for-sale securities																		—		—		—		—		—			—		—			(4	)		—			(4	)
Net loss																		—		—		—		—		—			—		—			—			(7,043	)		(7,043	)
Balance as of June 30, 2022																		—		—		12,637		13		9,195			—		162,105			(41	)		(130,996	)		31,081
Exchange of exchangeable shares																		—		—		83		—		(83	)		—		—			—			—			—
Issuance of common stock under stock plan, net																		—		—		37		—		—			—		(2	)		—			—			(2	)
Stock-based compensation																		—		—		—		—		—			—		1,448			—			—			1,448
Unrealized gain on available-for-sale securities																		—		—		—		—		—			—		—			5			—			5
Net loss																		—		—		—		—		—			—		—			—			(4,008	)		(4,008	)
Balance as of September 30, 2022																		—	$	—		12,757	$	13		9,112		$	—	$	163,551		$	(36	)	$	(135,004	)	$	28,524

								Accumulated
					Additional			Other									Series A Special Voting													Additional			Accumulated Other
	Common Stock				Paid-In			Comprehensive			Accumulated						Common Stock				Common Stock				Exchangeable Shares					Paid-In			Comprehensive			Accumulated
	Shares		Amount		Capital			Loss			Deficit			Total			Shares		Amount		Shares		Amount		Shares			Amount		Capital			Loss			Deficit			Total
Balance as of December 31, 2020		5,241	$	5	$	102,361		$	—		$	(106,287	)	$	(3,921	)		—	$	—		5,241	$	5		—		$	—	$	102,361		$	—		$	(106,287	)	$	(3,921	)
Stock-based compensation		—		—		1,177			—			—			1,177			—		—		—		—		—			—		1,177			—			—			1,177
Net loss		—		—		—			—			(4,157	)		(4,157	)		—		—		—		—		—			—		—			—			(4,157	)		(4,157	)
Balance as of March 31, 2021		5,241	$	5	$	103,538		$	—		$	(110,444	)	$	(6,901	)		—		—		5,241		5		—			—		103,538			—			(110,444	)		(6,901	)
Issuance of common stock under stock plan, net																		—		—		16		—		—			—		30			—			—			30
Stock-based compensation																		—		—		—		—		—			—		1,137			—			—			1,137
Net loss																		—		—		—		—		—			—		—			—			(5,430	)		(5,430	)
Balance as of June 30, 2021																		—		—		5,257		5		—			—		104,705			—			(115,874	)		(11,164	)
Issuance of common stock under stock plan, net																		—		—		452		—		—			—		1			—			—			1
Stock-based compensation																		—		—		—		—		—			—		1,148			—			—			1,148
Net loss																		—		—		—		—		—			—		—			—			(3,821	)		(3,821	)
Balance as of September 30, 2021																		—	$	—		5,709	$	5		—		$	—	$	105,854		$	—		$	(119,695	)	$	(13,836	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

	Three Months Ended						Nine Months Ended
	March 31,						September 30,
	2022			2021			2022			2021
Cash flows from operating activities:
Net loss	$	(6,754	)	$	(4,157	)	$	(17,805	)	$	(13,407	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		776			277			2,289			783
Stock-based compensation		1,171			1,177			4,357			3,461
Allowance for doubtful accounts								683			—
Change in fair value of warrant liability		—			39			—			(113	)
Amortization of debt discount		—			348			—			1,540
Accrued interest expense		—			165			4			661
Amortization of lease right-of-use assets		121			60			418			182
Change in operating lease liabilities		(107	)		(58	)		(462	)		(177	)
Other		152			9			199			26
Changes in assets and liabilities:
Accounts receivable		331			688			117			(16	)
Inventories		(698	)		155			(1,447	)		(756	)
Tax credits and receivables		(17	)		(246	)		23			(434	)
Prepaid expenses and other assets		(175	)		121			190			212
Deferred cost of net revenue								(600	)		—
Accounts payable		4			133			(193	)		925
Deferred revenue and other liabilities		(544	)		37			(1,192	)		56
Net cash used in operating activities		(5,740	)		(1,252	)		(13,419	)		(7,057	)
Cash flows from investing activities:
Purchases of property and equipment		(76	)		(9	)		(577	)		(57	)
Purchases of intangible assets		(20	)		—			(21	)		(95	)
Proceeds from maturities of marketable securities		4,240			—			11,534			—
Purchases of marketable securities and investments		(497	)		—
Purchases of marketable securities								(497	)		—
Net cash provided by (used in) investing activities		3,647			(9	)		10,439			(152	)
Cash flows from financing activities:
Taxes paid to net share settle equity awards		(9	)		—			(61	)		—
Repayment of loans								—			(184	)
Proceeds from exercise of stock options								—			31
Net proceeds from loan facility		—			552			—			1,262
Net proceeds from convertible debenture								—			5,545
Net cash provided by (used in) financing activities		(9	)		552			(61	)		6,654
Net decrease in cash and cash equivalents		(2,102	)		(709	)		(3,041	)		(555	)
Cash and cash equivalents at beginning of period		5,893			1,711			5,893			1,712
Cash and cash equivalents at end of period	$	3,791		$	1,002		$	2,852		$	1,157
Supplemental disclosure:
Recognition of right-of-use asset and lease liability	$	274		$	—
Unrealized loss on securities	$	37		$	—
Recognition of right-of-use assets and lease liabilities							$	1,003		$	—
Unrealized loss on available-for-sale securities							$	36		$	—
Settlement of loan facility against tax receivables							$	—		$	1,093
Fair value of new warrants issued recognized as debt discount							$	—		$	2,604

The accompanying notes are an integral part of these condensed consolidated financial statements.

Peraso Inc., formerly known as MoSys, Inc. (the Company), was incorporated in California in 1991 and reincorporated in 2000 in Delaware. The Company is a fabless semiconductor company specializing in the development of ~~mmWave technology, including 60GHz and 5G products, and~~millimeter wave (mmWave), which is generally described as the frequency band from 24 Gigahertz (GHz) to 300GHz, wireless technology. The Company derives revenue from selling its 60GHz and 5G semiconductor devices ~~licensing of intellectual property (IP)~~and modules and performance of non-recurring engineering ~~services (NRE).~~services. The Company also manufactures and sells high-performance memory semiconductor devices ~~that enable fast, intelligent data access and decision making~~ for a wide range of ~~markets.~~markets and receives royalties from licensees of its memory technology.

On September 14, 2021, the Company and its subsidiaries, 2864552 Ontario Inc. (Callco) and 2864555 Ontario Inc. (Canco), entered into an Arrangement Agreement (the Arrangement Agreement) with Peraso Technologies Inc. (Peraso Tech), a corporation existing under the laws of the province of Ontario, to acquire all of the issued and outstanding common shares of Peraso Tech (the Peraso Shares), including those Peraso Shares to be issued in connection with the conversion or exchange of secured convertible debentures and common share purchase warrants of Peraso Tech, as applicable, by way of a statutory plan of arrangement (the Arrangement) under the Business Corporations Act (Ontario). On December 17, 2021, following the satisfaction of the closing conditions set forth in the Arrangement Agreement, the Arrangement was completed and, the Company changed its name to “Peraso Inc.” and began trading on the Nasdaq Stock Market (the Nasdaq) under the symbol “PRSO.”

For accounting purposes, Peraso Tech, the legal subsidiary, ~~Peraso Tech,~~ has been treated as the accounting acquirer and the Company, the legal parent, has been treated as the accounting acquiree. The transaction was accounted for as a reverse acquisition in accordance with Financial Accounting Standards Board Accounting Standards Codification (ASC) No. 805, Business Combinations (ASC 805). Accordingly, these condensed consolidated financial statements are a continuation of Peraso Tech’s consolidated financial statements prior to December 17, 2021 and exclude the statements of operations and comprehensive loss, statement of stockholders’ equity ~~(deficit)~~ and statements of cash flows of the Company prior to December 17, 2021. See Note 2 for additional disclosure.

The accompanying condensed consolidated financial statements of the Company have been prepared without audit.

The condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited consolidated financial statements at that date. Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (GAAP) have been condensed or omitted in accordance with the rules and regulations of the Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in its most recent annual report on Form 10-K filed with the SEC.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary to summarize fairly the Company’s financial position, results of operations and cash flows for the interim periods presented. The operating results for the three and nine months ended ~~March 31,~~September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or for any other future period.

The Company incurred net losses of approximately $17.8 million for the nine months ended September 30, 2022 and $10.9 million for the year ended December 31, 2021 and had an accumulated deficit of approximately $135.0 million as of September 30, 2022. These and prior year losses have resulted in significant negative cash flows and have required the Company to raise substantial amounts of additional capital. To date, the Company has primarily financed its operations through multiple offerings of common stock and issuance of convertible notes and loans to investors and affiliates.

The Company expects to continue to incur operating losses for the foreseeable future as it secures additional customers and continues to invest in the commercialization of its products. The Company will need to increase revenues substantially beyond levels that it has attained in the past in order to generate sustainable operating profit and sufficient cash flows to continue doing business without raising additional capital from time to time. As a result of the Company’s expected operating losses and cash burn for the foreseeable future, as well as recurring losses from operations, if the Company is unable to raise sufficient capital through additional debt or equity arrangements, there will be uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern within one year from the date of issuance of these condensed consolidated financial statements. These condensed consolidated financial statements do not include any adjustments that might result from this uncertainty. There can be no assurance that such additional capital, whether in the form of debt or equity financing, will be sufficient or available and, if available, that such capital will be offered on terms and conditions acceptable to the Company. The Company’s primary focus is producing and selling its products. If the Company is unsuccessful in these efforts, it will need to implement additional cost reduction strategies, which could further affect its near- and long-term business plan. These efforts may include, but are not limited to, reducing headcount and curtailing business activities.

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year ends on December 31 of each calendar year. Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations or cash flows. The Company previously classified intangible asset amortization expense related to the developed technology and customer relationships intangibles within research and development expenses (R&D) in its condensed consolidated statements of operations and comprehensive loss. Amortization expense on the developed technology intangible asset is now classified within cost of net revenue, and amortization expense on customer relationships is now classified in selling, general and administrative expenses (SG&A). Prior period amounts have been conformed to the current period presentation. See Note 5 for additional disclosure.

The Company is subject to risks from, among other things, competition associated with the industry in general, other risks associated with financing, liquidity requirements, rapidly changing customer requirements, limited operating history and the volatility of public markets.

The global outbreak of the coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization and a national emergency by the U.S. government in March 2020. This has negatively affected the U.S. and global economy, disrupted global supply chains, significantly restricted travel and transportation, resulted in mandated closures and orders to “shelter-in-place” and created significant disruption of the financial markets. The full extent of the COVID-19 impact on the Company’s operational and financial performance will depend on future developments, including the duration and spread of the pandemic and related actions taken by U.S. and foreign government agencies to prevent disease spread, all of which are uncertain, out of the Company’s control, and cannot be predicted.

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses recognized during the reported period. Material estimates may include assumptions made in determining reserves for uncollectible receivables, inventory write-downs, impairment of long-term assets, purchase price allocations, valuation allowance on deferred tax assets, accruals for potential liabilities and assumptions made in valuing equity instruments. Actual results could differ from those estimates.

The Company has invested its excess cash in money market accounts, certificates of deposit, corporate debt, government-sponsored enterprise bonds and municipal bonds and considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. Investments with original maturities greater than three months and remaining maturities less than one year are classified as short-term investments. Investments with remaining maturities greater than one year are classified as long-term investments. Management generally determines the appropriate classification of securities at the time of purchase. All securities are classified as available-for-sale. The Company’s available-for-sale short-term and long-term investments are carried at fair value, with the unrealized holding gains and losses reported in accumulated other comprehensive income (loss). Realized gains and losses and declines in the value judged to be other-than-temporary are included in the other income, net line item in the condensed consolidated statements of operations. The cost of securities sold is based on the specific identification method.

The Company measures the fair value of financial instruments using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels:

Level 1—Inputs used to measure fair value are unadjusted quoted prices that are available in active markets for the identical assets or liabilities as of the reporting date.

Level 2—Pricing is provided by third party sources of market information obtained through the Company’s investment advisors, rather than models. The Company does not adjust for, or apply, any additional assumptions or estimates to the pricing information it receives from advisors. The Company’s Level 2 securities include cash equivalents and available-for-sale securities, which consisted primarily of certificates of deposit, corporate debt, and government agency and municipal debt securities from issuers with high-quality credit ratings. The Company’s investment advisors obtain pricing data from independent sources, such as Standard & Poor’s, Bloomberg and Interactive Data Corporation, and rely on comparable pricing of other securities because the Level 2 securities are not actively traded and have fewer observable transactions. The Company considers this the most reliable information available for the valuation of the securities.

Level 3—Unobservable inputs that are supported by little or no market activity and reflect the use of significant management judgment are used to measure fair value. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions. The determination of fair value for Level 3 investments and other financial instruments involves the most management judgment and subjectivity.

The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

The Company establishes an allowance for doubtful accounts to ensure that its trade receivables balances are not overstated due to uncollectibility. The Company performs ongoing customer credit evaluations within the context of the industry in which it operates and generally does not require collateral from its customers. A specific allowance of up to 100% of the invoice value is provided for any problematic customer balances. Delinquent account balances are written off after management has determined that the likelihood of collection is remote. The Company grants credit only to customers deemed creditworthy in the judgment of management. The allowance for doubtful accounts receivable was 0approximately $683,000 as of ~~March 31,~~September 30, 2022 and approximately $61,000 as of December 31, 2021.

The Company values its inventories at the lower of cost, which approximates actual cost on a first-in, first-out basis, or net realizable value. Costs of inventories primarily consisted of material and third party assembly costs. The Company records inventory reserves for estimated obsolescence or unmarketable inventories based upon assumptions about future demand and market conditions. Once a reserve is established, it is maintained until the product to which it relates is sold or otherwise disposed of. If actual market conditions are less favorable than those expected by management, additional adjustment to inventory valuation may be required. Charges for obsolete and slow-moving inventories are recorded based upon an analysis of specific identification of obsolete inventory items and quantification of slow moving inventory items. The Company recorded write-downs of inventory of approximately ~~$114,000~~$420,000 and $56,000 during the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and ~~recorded 0 write-downs of inventory during the three months ended March 31, 2021.~~2021, respectively.

The Company is registered for the Canadian federal and provincial goods and services taxes. As such, the Company is obligated to collect from third parties and is entitled to claim sales taxes paid on its expenses and capital expenditures incurred in Canada.

~~In addition, as a~~The Company participated in the Canadian ~~Controlled Private Corporation (CCPC), the Company is also a part of the~~government’s Scientific Research and Experimental Development ~~(SR&ED)~~(SRED) Program, which uses tax incentives to encourage Canadian businesses ~~of all sizes and in all sectors~~ to conduct research and development (R&D) in Canada. As a part of the program, the Company may be entitled to a receivable in the form of tax ~~credit~~credits or ~~incentive.~~incentives. The Company records refundable tax credits as a reduction of expense and receivable when the Company can reasonably estimate the amounts and it is more likely than not, ~~they~~the credit will be received.

A government refund or subsidy that is compensation for expenses or losses already incurred, or for which there are no future related costs, is recognized in the statement of operations in the period in which it becomes receivable.

As of December 17, 2021, Peraso Tech ceased to be a ~~CCPC~~Canadian Controlled Private Corporation, as defined by the government of Canada, and the Company is no longer eligible for the expenditure refund program. However, it is eligible for a tax credit of 15% on qualified ~~SR&ED~~SRED expenditures. Unused SRED tax credits can be carried back three years or forward for 20 ~~years~~years.

Intangible assets are recorded at cost and amortized on a straight-line method over their estimated useful lives of three to ten years. Amortization of developed technology and other intangibles directly related to the Company’s products is included in cost of net revenue, while amortization of customer relationships and other intangibles not associated with the Company’s products is included in SG&A in the condensed consolidated statements of operations.

The Company regularly reviews the carrying value and estimated lives of its long-lived assets and finite-lived intangible assets to determine whether indicators of impairment may exist which warrant adjustments to carrying values or estimated useful lives. The determinants used for this evaluation include management’s estimate of the asset’s ability to generate positive income from operations and positive cash flow in future periods as well as the strategic significance of the assets to the Company’s business objective. Should an impairment exist, the impairment loss would be measured based on the excess of the carrying amount of the long-lived asset group over the asset’s fair value.

Intangible assets acquired in business combinations are accounted for based on the fair value of assets purchased and are amortized over the period in which economic benefit is estimated to be received. Intangible assets subject to amortization, including those acquired in business combinations were as follows (amounts in thousands):

Developed technology primarily consisted of MoSys’ products that have reached technological feasibility and primarily relate to its memory semiconductor products and technology. The value of the developed technology was determined by discounting estimated net future cash flows of these products. The Company is amortizing the developed technology on a straight-line basis over four years. Amortization related to developed technology of $0.4 million and $1.1 million for the three and nine months ended September 30, 2022, respectively, has been included in cost of net revenue in the condensed consolidated statements of operations and comprehensive loss.

Customer relationships relate to the Company's ability to sell existing and future versions of products to MoSys’ customers existing at the time of the arrangement. The fair value of the customer relationships was determined by discounting estimated net future cash flows from the customer relationships. The Company is amortizing customer relationships on a straight-line basis over an estimated life of 4 years. Amortization related to customer relationships of $0.2 million and $0.5 million for the three and nine months ended September 30, 2022, respectively, has been included in selling, general and administrative expense in the condensed consolidated statements of operations and comprehensive loss.

Amortization expense was $0.5 million and $1.6 million for the three and nine months ended September 30, 2022, respectively. There was no material amortization expense for the three and nine months ended September 30, 2021.

As of September 30, 2022, estimated future amortization expense related to intangible assets was as follows (in thousands):

The Company determines the amount of a potential goodwill impairment by comparing the fair value of the reporting unit with its carrying amount. To the extent the carrying value of a reporting unit exceeds its fair value, a goodwill impairment charge is recognized.

The Company has determined that it has a single reporting unit for purposes of performing its goodwill impairment test. As the Company uses the market approach to determine the step one fair value of the reporting unit, the price of its common stock is an important component of the fair value calculation. If the Company’s stock price experiences significant price and volume fluctuations, this will impact the fair value of the reporting unit, which can lead to potential impairment in future periods. The Company reviews goodwill for impairment on an annual basis or whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. The Company first assesses qualitative factors to determine whether it is more-likely-than-not that the fair value of the reporting unit is less than the carrying amount as a basis for determining whether it is necessary to perform an impairment test. If the qualitative assessment warrants further analysis, the Company compares the fair value of the reporting unit to its carrying value. The fair value of the reporting unit is determined using the market approach. If the fair value of the reporting unit exceeds the carrying value of net assets of the reporting unit, goodwill is not impaired. If the carrying value of the reporting unit’s goodwill exceeds its fair value, then the Company must record an impairment charge equal to the difference.

To date, as of September 30, 2022, the Company has not identified any goodwill impairment. However, current macroeconomic conditions, which have been impacted by the COVID-19 pandemic and inflation, could negatively impact our business and stock price and trigger the Company to test for impairment. The Company will continue to evaluate for impairment indicators, as necessary, on a quarterly basis.

ASC No. 842, Leases (ASC 842) requires an entity to recognize a right-of-use asset and a lease liability for all leases with terms longer than 12 months. The Company adopted ASC 842 utilizing the modified retrospective transition method. The Company elected the practical expedient afforded in ASC 842 in which the Company did not reassess whether any contracts that existed prior to adoption have or contain leases or the classification of its existing leases.

The Company recognizes revenue in accordance with~~Financial Accounting Standards Board (FASB)~~ ASC Topic 606, Revenue from Contracts with Customers and its amendments (ASC 606). As described below, the analysis of contracts under ASC 606 supports the recognition of revenue at a point in time, resulting in revenue recognition timing that is materially consistent with the Company’s historical practice of recognizing product revenue when title and risk of loss pass to the customer.

The Company generates revenue primarily from sales of integrated circuits and module products, performance of engineering services and licensing of its intellectual property. Revenues are recognized when control is transferred to customers in amounts that reflect the consideration the Company expects to be entitled to receive in exchange for those goods. Revenue recognition is evaluated through the following five steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied.

Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied. The majority of the Company's contracts have a single performance obligation to transfer products. Accordingly, the Company recognizes revenue when title and risk of loss have been transferred to the customer, generally at the time of shipment of products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products and is generally based upon a negotiated, formula, list or fixed price. The Company sells its products both directly to customers and through distributors generally under agreements with payment terms typically 60 days or less.

The Company may record an estimated allowance, at the time of shipment, for future returns and other charges against revenue consistent with the terms of sale.

The Company’s licensing contracts typically provide for royalties based on the licensee’s use of the Company’s memory technology in its currently shipping commercial products. The Company estimates its royalty revenue in the calendar quarter in which the licensee uses the licensed technology. Payments are received in the subsequent quarter. The Company also generates revenue from licensing its technology. The Company recognizes license fees as revenue at the point of time when the control of the license has been transferred and the Company has no continuing performance obligations to the customer.

Engineering and development contracts with customers generally contain a single performance obligation that is delivered over time. Revenue is recognized using an output method that is consistent with the satisfaction of the performance obligation as a measure of progress.

During the three months ended September 30, 2022, the Company had $1.1 million of product shipments for which the revenue recognition criteria under ASC 606 had not been met. Accordingly, the Company has deferred the cost of net revenue associated with these shipments, and the amount deferred has been presented as deferred cost of net revenue in the condensed consolidated balance sheets.

The Company’s contract liabilities consist of advance customer payments and deferred revenue. The Company classifies advance customer payments and deferred revenue as current or non-current based on the timing of when the Company expects to recognize revenue. As of September 30, 2022 and December 31, 2021, contract liabilities were in a current position and included in deferred revenue.

During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, the Company recognized approximately ~~$15,000~~$156,000 of revenue that had been included in deferred revenue as of December 31, 2021.

The Company does not have significant financing components, as payments from customers are typically due within 60 days of invoicing, and the Company has elected the practical expedient to ~~net~~not value financing components that are less than one year. Shipping and handling costs are generally incurred by the customer, and, therefore, are not recorded as revenue.

Cost of net revenue consists primarily of direct and indirect costs of product ~~sales.~~sales, including amortization of intangible assets and depreciation of production-related fixed assets.

A grant or subsidy that is compensation for expenses or losses already incurred, or for which there are no future related costs, is recognized in the statement of operations in the period in which it becomes receivable.

Starting in 2020, certain Canadian businesses, which experienced a drop in revenue during the COVID-19 pandemic, became eligible for a rent and wage ~~subsidy~~subsidies from the Canadian government. The Company’s subsidiary, Peraso Tech, began receiving ~~this subsidy~~subsidies on a monthly basis beginning in the fourth quarter of ~~2020.~~2020 and ending in the fourth quarter of 2021.

During the ~~three~~nine months ended ~~March 31,~~September 30, 2021, the Company recognized payroll subsidies of ~~$425,525~~$1,102,616 as a reduction in the associated wage costs and rent subsidies of ~~$77,780~~$195,995 as a reduction of operating expenses in the condensed consolidated statement of operations.

The Company periodically issues stock options and restricted stock awards to employees and non-employees. The Company accounts for such grants based on ASC No. 718, whereby the value of the award is measured on the date of grant and recognized as compensation expense on a straight-line basis over the vesting period. The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing (Black Scholes) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes model. The assumptions used in the Black-Scholes model could materially affect compensation expense recorded in future periods.

The functional currency of the Company is the U.S dollar. All foreign currency transactions are initially measured and recorded in an entity’s functional currency using the exchange rate on the date of the transaction. All monetary assets and liabilities are remeasured at the end of each reporting period using the exchange rate at that date. All non-monetary assets and related expense, depreciation or amortization are not subsequently remeasured and are measured using the historical exchange rate. An average exchange rate may be used to recognize income and expense items earned or incurred evenly over a period. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the statement of operations, except for the gains and losses arising from the conversion of the carrying amount of the foreign currency denominated convertible preferred shares into the functional currency that are presented as adjustment to the net loss to arrive at net loss attributable to common stockholders.

Basic net loss per share is computed by dividing net loss for the period by the weighted-average number of exchangeable shares and shares of common stock outstanding during the period. Diluted net loss per share gives effect to all potentially dilutive exchangeable and common shares outstanding during the period. Potentially dilutive common shares consist of incremental exchangeable shares and shares of common stock issuable upon the achievement of escrow terms, exercise of stock options, vesting of stock awards and exercise of warrants.

The following table sets forth securities outstanding that were excluded from the computation of diluted net loss per share as their inclusion would be anti-dilutive (in thousands):


	March 31,				September 30,
	2022		2021		2022		2021
Escrow shares		1,815		—
Escrow shares - exchangeable shares						1,313		—
Escrow shares - common stock						502		—
Options to purchase common stock		1,545		1,042		1,514		1,034
Unvested restricted common stock units		75		—		1,229		—
Convertible debt		—		3,272		—		5,500
Warrants		134		375
Common stock warrants						134		508
Total		3,569		4,689		4,692		7,042

In June 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments—Credit Losses. This ASU added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes an allowance for its estimate of expected credit losses and applies to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. This update is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years

for smaller reporting companies. The Company ~~is still evaluating~~does not expect that the adoption of ASU No. 2016-13 will have a significant impact ~~of this accounting guidance~~ on ~~its results of operations and~~the Company's consolidated financial ~~position.~~statements.

In ~~August 2020,~~May 2021, the FASB issued ASU ~~No. 2020-06 (ASU 2020-06)~~2021-04, Earnings Per Share (Topic 260), ~~Debt—~~Debt ~~with Conversion~~— Modifications and ~~Other Options~~Extinguishments (Subtopic ~~470-20)~~470-50), Compensation — Stock Compensation (Topic 718), and Derivatives and ~~Hedging—~~Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for ~~Convertible Instruments and Contracts in~~Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (ASU 2021-04). ASU 2021-04 provides guidance as to how an ~~Entity’s Own Equity. The ASU will simplify~~issuer should account for a modification of the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models will result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that: i) are not clearly and closely related to the host contract, ii) meet the definitionterms or

conditions or an exchange of a ~~derivative, and iii) do not qualify~~freestanding equity-classified written call option (i.e., a warrant) that remains classified after modification or exchange as an exchange of the original instrument for a ~~scope exception from derivative~~new instrument. An issuer should measure the effect of a modification or exchange as the difference between the fair value of the modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange and then apply a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and ~~(2) convertible~~modifications unrelated to equity issuance and debt ~~instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The~~origination or modification). ASU ~~also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06 will be~~2021-04 is effective for ~~the Company January 1, 2024, and early adoption is permitted, but no earlier than January 1,~~all entities for fiscal years beginning after December 15, 2021, including interim periods within ~~that year.~~those fiscal years. An entity should apply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. The Company ~~is currently evaluating what effect(s) the~~adopted ASU 2021-04 effective January 1, 2022. The adoption of ASU ~~2020-06 may~~2021-04 did not have any impact on ~~its~~the Company’s consolidated financial ~~statements, but the Company~~statement presentation or disclosures.

Management does not believe ~~the~~that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact ~~of the ASU will be material to its financial position, results of operations and cash flows. The effect will largely depend~~ on ~~the composition and terms of~~ the Company’s financial ~~instruments at the time of adoption.~~ statement presentation or disclosures.

As discussed in Note 1, on September 14, 2021, the Company and its newly formed subsidiaries, Callco and Canco, entered into the Arrangement Agreement with Peraso Tech.Prior to the Arrangement, as a fabless semiconductor company, the Company’s primary focus was the manufacture and sale of high-performance memory semiconductor devices for a wide range of markets. Peraso Tech was also a fabless semiconductor company specializing in the development of mmWave technology, including 60GHz and 5G products, and deriving revenue from selling semiconductor devices, proprietary modules based on its semiconductor devices and performance of non-recurring engineering services. The primary reason for the business combination was to produce a larger fabless semiconductor company with greater size and scale with access to the public capital markets for the benefit of the stockholders of both companies.

On December 17, 2021, following the satisfaction of the closing conditions set forth in the Arrangement Agreement, including approvals from the stockholders of the Company and Peraso Tech, the Arrangement was completed.

Pursuant to the completion of the Arrangement, each Peraso Share that was issued and outstanding immediately prior to December 17, 2021 was converted into the right to receive 0.045239122387267 (the Exchange Ratio) newly issued shares of common stock of the Company or shares of Canco, which are exchangeable for shares of the Company’s common stock (Exchangeable Shares), at the election of each former Peraso Tech stockholder. In addition, all of Peraso Tech’s outstanding stock options and other securities exercisable or exchangeable for, or convertible into, and any other rights to acquire Peraso Shares were exchanged for securities exercisable or exchangeable for, or convertible into, or other rights to acquire the Company’s common stock. Immediately following the completion of the Arrangement, the former security holders of Peraso Tech owned approximately 61%, on a fully-diluted basis, of the Company’s common stock, and the former shareholders of Peraso Tech, as a group, obtained control of the Company. While the Company was the legal acquirer of Peraso Tech, Peraso Tech was deemed to be the acquirer for accounting purposes.

In addition, pursuant to the terms of the Arrangement Agreement, (i) certain warrants to purchase Peraso Shares outstanding immediately prior to the closing of the Arrangement were exercised in consideration for the issuance of Peraso Shares; (ii) each convertible debenture of Peraso Tech outstanding immediately prior to the closing of the Arrangement and all principal and accrued but unpaid interest thereon was converted into Peraso Shares at a conversion price equal to the conversion price set out in each such debenture; and (iii) each outstanding option to purchase Peraso Shares (each, a Peraso Option) was exchanged for a replacement option to purchase such number of shares of common stock that was equal to the product of (a) the number of Peraso Shares subject to the Peraso Options immediately before the closing of the Arrangement and (b) the Exchange Ratio, rounded down to the nearest whole number of shares of common stock.

Upon the closing of the Arrangement, an aggregate of 9,295,097 Exchangeable Shares and 3,558,151 shares of common stock were issued to the holders of Peraso Shares. Of such shares, pursuant to the terms of the Agreement, the Company held in escrow an aggregate of 1,312,878 Exchangeable Shares and 502,567 shares of common stock

~~(collectively,~~ (collectively, the Escrow Shares). The Escrow Shares are escrowed pursuant to the terms of an escrow agreement on a pro rata basis from the aggregate consideration received by the holders of Peraso Shares, subject to the offset by the Company for any losses in accordance with the Agreement. Such Escrow Shares shall be released, subject to any offset claim, upon the satisfaction of the earlier of: (a) any date following the first anniversary of December 17, 2021 and prior to December 17, 2024 where the volume weighted average price of the common stock for any 20 trading days within a period of 30 consecutive trading days is at least $8.57 per share, subject to adjustment for stock splits or other similar transactions; (b) the date of any sale of all or substantially all of the assets or shares of the Company; or (c) the date of any bankruptcy,

insolvency, restructuring, receivership, administration, wind-up, liquidation, dissolution, or similar event involving the Company. All and any voting rights and other stockholder rights, other than with respect to dividends and distributions, with respect to the Escrow Shares are suspended until the Escrow Shares are released from escrow.

The Exchangeable Share structure is commonly used for cross-border transactions of this nature so as to provide non-tax-exempt Canadian shareholders with the same economic rights and benefits as holders of the Company’s shares into which the Exchangeable Shares are exchangeable, while allowing those Canadian shareholders to benefit from the tax-rollover available on the issuance of the Exchangeable Shares. In general terms, by choosing to acquire Exchangeable Shares from Canco, such a former Peraso Tech shareholder was able to rely on a rollover rule in the Income Tax Act (Canada) in order to defer any capital gain that he/she/it would have otherwise realized.

Callco was incorporated to exercise the call rights, while Canco was incorporated to acquire the shares of Peraso Tech from Canadian shareholders that wished to receive Exchangeable Shares as consideration, so it was a tax deferred transaction for such Canadian shareholders. The use of a separate entity, Callco, helps maximize cross border paid-up capital, which represents the amount that can generally be distributed free of Canadian withholding tax. The call rights also allow Callco to “purchase” the Exchangeable Shares rather than having them redeemed by Canco on a redemption or retraction or in connection with a liquidity event, thus avoiding the adverse deemed dividend tax consequences to shareholders that may arise from a redemption or retraction of Exchangeable Shares.

Holders of Exchangeable Shares have the right at any time (the Retraction Right) to retract or redeem any or all of the Exchangeable Shares owned by them for an amount per share equal to the market price of a share of the Company’s common stock plus the full amount of all declared and unpaid dividends on such Exchangeable Share (the Exchangeable Share Purchase Price). The Exchangeable Share Purchase Price is payable only by the Company delivering or causing to be delivered to the relevant holder one share of the Company’s common stock for each Exchangeable Share purchased plus a cash amount equal to the amount of any accrued and unpaid dividends on such Exchangeable Share. The Company and Callco each have an overriding right, in the event that a holder of Exchangeable Shares exercises its Retraction Right, to redeem from such holder all, but not less than all, of the Exchangeable Shares tendered for redemption.

The Exchangeable Shares are subject to redemption by the Company, Callco and Canco at the Exchangeable Share Purchase Price, on the “Redemption Date,” which date shall be no earlier than the seventh anniversary of the date on which Exchangeable Shares are first issued, unless: (a) less than 10% of the aggregate number of Exchangeable Shares issued remain outstanding; (b) there is a change in control of the Company (defined generally as (i) any merger, amalgamation, arrangement, takeover bid or tender offer, material sale of shares or rights or interests that results in the holders of outstanding voting securities of the Company directly or indirectly owning, or exercising control or direction over, voting securities representing less than 50% of the total voting power of all of the voting securities of the surviving entity; or (ii) any sale or disposition of all or substantially of the Company’s assets), and (c) upon the occurrence of certain other events. The Exchangeable Share Purchase Price is payable only by the Company delivering or causing to be delivered to the relevant holder one share of the Company’s common stock for each Exchangeable Share purchased plus a cash amount equal to the amount of any accrued and unpaid dividends on such Exchangeable Share.

In the event of the liquidation, dissolution or winding-up of Canco, holders of Exchangeable Shares have the right to receive in respect of each Exchangeable Share held by such holder, an amount per share equal to the Exchangeable Share Purchase Price, which shall be satisfied in full by Canco by delivering to such holder one Company Share, plus an amount equal to the Dividend Amount. The Company and Callco each have an overriding right to purchase from all holders all but not less than all of the Exchangeable Shares upon the occurrence of such events.

In addition, the Company and Callco have the right to purchase all outstanding Exchangeable Shares at the Exchangeable Share Purchase Price if there is a change of law that permits holders of Exchangeable Shares to exchange their Exchangeable Shares for shares of common stock on a basis that will not require holders to recognize any gain or loss or any actual or deemed dividend for Canadian tax purposes.

The holders of Exchangeable Shares have an “automatic exchange right” in the event of any insolvency, liquidation, dissolution or winding-up or in general, related proceedings, of the Company for an amount per share equal to the Exchangeable Share Purchase Price.

It is expected that Callco will exercise its call rights, as that is more beneficial to the holders of the Exchangeable Shares. Once Callco acquires the Exchangeable Shares from a holder, it (Callco and the Company) is obligated to deliver the Company shares to the holder. Callco discharges this obligation by arranging for the Company to issue and deliver those shares to the holders on behalf of Callco. As consideration for satisfying the delivery obligation, Callco would issue its own shares to the Company.

There are no cash redemption features, as all redemption and exchange scenarios are payable in a share of the Company’s common stock. Neither Canco, Callco, or the Company assume any tax liabilities of a former Peraso Tech shareholder who acquired Exchangeable Shares under the plan of arrangement. The purchase price computed upon the exercise of rights pertaining to retraction, redemption, or liquidation, or otherwise giving rise to a purchase or cancellation of an Exchangeable Share, will, in all cases, consist of a 1:1 exchange involving the Company’s common stock, regardless of the market price of a share of the Company’s common stock.

In connection with the Arrangement, on December 15, 2021, the Company filed the Certificate of Designation of Series A Special Voting Preferred Stock (the Certificate) with the Secretary of State of the State of Delaware to designate Series A Special Voting Preferred Stock (the Special Voting Share) in accordance with the terms of the Arrangement Agreement in order to enable the holders of Exchangeable Shares to exercise their voting rights. The Special Voting Share was issued to a third-party administrative agent (the Agent) solely to facilitate the exercise of rights by holders of Exchangeable Shares. The rights of the Agent, as holder of the Special Voting Share, are limited to effecting the rights of the holders of the Exchangeable Shares; the Special Voting Share does not confer any independent rights to the Agent. Under the Certificate, when all of the Exchangeable shares have been converted into shares of the Company’s common stock, the Special Voting Share shall be automatically cancelled and shall not be reissued. Each Exchangeable Share is exchangeable for one share of common stock of the Company and while outstanding, the Special Voting Share enables holders of Exchangeable Shares to cast votes on matters for which holders of the common stock are entitled to vote, and by virtue of the share terms relating to the Exchangeable Shares, enable the Exchangeable Shares to receive dividends that are economically equivalent to any dividends declared with respect to the shares of common stock. As the Special Voting Share does not participate in dividends (only the Exchangeable Shares participate in dividends) and is not entitled to participate in the residual interest of the Company, it is not classified as an equity instrument in the Company’s financial statements.

The Exchangeable Shares, which can be converted into common stock at the option of the holder and have the same voting and dividend rights as common stock, are similar in substance to shares of common stock. Further, Canco and Callco are non-substantive entities, which are looked through with the Exchangeable Shares being, in substance, common stock ~~and, therefore,~~of the Company. Therefore, the Exchangeable Shares have been included in the determination of outstanding common stock. The Special Voting Share was issued to a third-party administrative agent (the Agent) solely to facilitate the exercise of rights by holders of Exchangeable Shares, The rights of the Agent, as holder of the Special Voting Share, are limited to effecting the rights of the holders of the Exchangeable Shares; the Special Voting Share does not confer any independent rights to the Agent. Under the Certificate, when all of the Exchangeable shares have been converted into shares of the Company’s common stock, the Special Voting Share shall be automatically cancelled and shall not be reissued.

Pursuant to ASC 805, the transaction was accounted for as a reverse acquisition because: (i) the stockholders of Peraso Tech owned the majority of the outstanding common stock of the Company after the share exchange; (ii) Peraso Tech appointed a majority of the Company’s board of directors; and (iii) Peraso Tech determined the officers of the Company.

In the reverse acquisition, the accounting acquirer did not issue any consideration to the accounting acquiree, rather the accounting acquiree issued its equity shares to the owners of the accounting acquirer in exchange for the accounting acquirer’s shares. The acquisition date fair value of the consideration transferred by the accounting acquirer for its interest in the accounting acquiree was calculated by Peraso Tech, as the fair value of the consideration effectively transferred. In accordance with ASC 805, the consideration effectively transferred between the Company (a public company as the accounting acquiree) and Peraso Tech (a private company as the accounting acquirer), was calculated as the fair value of the Company’s equity including the fair value of its common shares outstanding and its warrants, plus the portion of the share-based award fair value allocated to the pre-combination service of the accounting acquiree’s awards. The fair value of the total consideration effectively transferred ~~was determined to be $37.6 million.~~is summarized in the following table (in thousands, except per-share amount):

The following table summarizes the final allocation of the purchase price to the net assets acquired based on the respective fair value of the acquired assets and assumed liabilities of the accounting acquiree, which is the Company.

Unaudited ~~proforma~~pro forma results of operations for the three and nine months ended ~~March 31,~~September 30, 2021 are included below as if the business combination occurred on January 1, 2021. This summary of the unaudited pro forma results of operations is not necessarily indicative of what the Company’s results of operations would have been had Peraso Tech been acquired at the beginning of 2021, nor does it purport to represent results of operations for any future periods.

	Three Months Ended			Three Months Ended			Nine Months Ended
	March 31, 2021
	(in thousands)
(in thousands)				September 30, 2021			September 30, 2021
Revenue	$	2,439		$	3,354		$	7,659
Net loss	$	(5,526	)	$	(5,535	)	$	(17,695	)

The estimated fair values of financial instruments outstanding were (in thousands):

	March 31, 2022									September 30, 2022
			Unrealized		Unrealized			Fair				Unrealized		Unrealized			Fair
	Cost		Gains		Losses			Value		Cost		Gains		Loss			Value
Cash and cash equivalents	$	3,791	$	0	$	0		$	3,791	$	2,852	$	—	$	—		$	2,852
Short-term investments		6,001		0		(8	)		5,993		1,107		—		(36	)		1,071
Long-term investments		2,428		0		(29	)		2,399
	$	12,220	$	0	$	(37	)	$	12,183	$	3,959	$	—	$	(36	)	$	3,923

	December 31, 2021									December 31, 2021
			Unrealized		Unrealized			Fair				Unrealized		Unrealized			Fair
	Cost		Gains		Losses			Value		Cost		Gains		Losses			Value
Cash and cash equivalents	$	5,893	$	0	$	0		$	5,893	$	5,893	$	—	$	—		$	5,893
Short-term investments		9,276		0		(9	)		9,267		9,276		—		(9	)		9,267
Long-term investments		2,935		0		(7	)		2,928		2,935		—		(7	)		2,928
	$	18,104	$	0	$	(16	)	$	18,088	$	18,104	$	—	$	(16	)	$	18,088

The following table represents the Company’s fair value hierarchy for its financial assets (cash equivalents and investments) (in thousands):

	March 31, 2022								September 30, 2022
	Fair Value		Level 1		Level 2		Level 3		Fair Value		Level 1		Level 2		Level 3
Money market funds	$	41	$	41	$	—	$	—	$	72	$	72	$	—	$	—
Corporate notes and commercial paper	$	8,392	$	—	$	8,392	$	—	$	1,071	$	—	$	1,071	$	—
	$	8,433	$	41	$	8,392	$	—	$	1,143	$	72	$	1,071	$	—

There were 0no transfers in or out of Level 1 and Level 2 securities during the ~~three~~nine months ended ~~March 31,~~September 30, 2022 or December 31, 2021.

	March 31,		December 31,		September 30,		December 31,
	2022		2021		2022		2021
	(in thousands)				(in thousands)
Inventories:
Raw materials	$	1,408	$	879	$	1,416	$	879
Work-in-process		2,327		2,170		2,728		2,170
Finished goods		786		775		1,127		775
	$	4,521	$	3,824	$	5,271	$	3,824

Prior to April 1, 2022, the Company classified amortization expense related to the developed technology and customer relationships intangible assets within R&D in its condensed consolidated statements of operations and comprehensive loss. Amortization expense on the developed technology intangible asset is now classified within cost of net revenue, and amortization expense on customer relationships is now classified in SG&A. Prior period amounts have been conformed to the current period presentation. The reclassification had no impact on the Company's net loss or cash flows for the three months ended March 31, 2022 and nine months ended September 30, 2022.

The effects of the adjustments for the three months ended March 31, 2022 were as follows (in thousands):

The Company has ~~three~~five facility leases that it accounts for under ASC 842, and these include the operating leases for its corporate facility in San Jose, California, and facilities in Toronto, Markham and Waterloo, Ontario, Canada. The ~~San Jose lease expires in July 2022, and the~~ Waterloo and Toronto leases expire in September 2022 and December 2023, respectively. ~~On March 1,~~The current San Jose lease with a sublessor expires in July 2022, and the Company entered into a new, direct lease with the facility landlord, dated April 13, 2022, for an 18-month term, which commenced July 15, 2022. In addition, on May 26, 2022, the Company entered into a ~~36 month finance~~new lease ~~agreement~~ for ~~the~~a facility in Markham, Ontario with a 60-month term, which commenced June 21, 2022. The Markham landlord also provided a lease ~~of equipment resulting in the recognition of a right-of-use asset and lease liability on the balance sheet~~incentive of approximately ~~$274,000.~~$220,000 (the Incentive), which will be payable to the Company as follows: one-half of the Incentive payable subsequent to the completion of the improvements to the leased space and the second half-ratably on an annual basis commencing with the second year of the lease.

The right-to-use assets and corresponding liabilities for the facility leases were measured at the present value of the future minimum lease payments. The discount rate used to measure the lease assets and liabilities were 8%. Lease expense is recognized on a straight-line basis over the lease term.

On March 1, 2022, the Company entered into a 36-month finance lease agreement for the lease of equipment resulting in the recognition of a right-of-use asset and lease liability on the balance sheet of approximately $274,000.

The following table provides the details of right-of-use assets and lease liabilities as of September 30, 2022 (in thousands):

Future minimum payments under the leases at ~~March 31,~~September 30, 2022 are listed in the table below (in thousands):

The following table provides the details of supplemental cash flow information (in thousands):

		Three Months Ended					Nine Months Ended
		March 31,					September 30,
		2022		2021			2022		2021
Cash paid for amounts included in the measurement of lease liabilities:	Cash paid for amounts included in the measurement of lease liabilities:					Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for leases	Operating cash flows for leases	$	129	$	71	Operating cash flows for leases	$	504	$	273

Rent expense was approximately ~~$0.1~~$0.2 million for each of the ~~three month~~three-month periods ended ~~March 31,~~September 30, 2022 and 2021. Rent expense was approximately $0.5 million for the nine months ended September 30, 2022 and $0.3 million for the nine months ended September 30, 2021. In addition to the minimum lease payments, the Company is responsible for property taxes, insurance and certain other operating costs related to the leased facilities and equipment.

In the ordinary course of business, the Company enters into contractual arrangements under which it may agree to indemnify the counterparties from any losses incurred relating to breach of representations and warranties, failure to perform certain covenants, or claims and losses arising from certain events as outlined within the particular contract, which may include, for example, losses arising from litigation or claims relating to past performance. Such indemnification clauses may not be subject to maximum loss clauses. The Company has also entered into indemnification agreements with its officers and directors. No material amounts were reflected in the Company’s condensed consolidated financial statements for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021 related to these indemnifications.

The Company has not estimated the maximum potential amount of indemnification liability under these agreements due to the limited history of prior claims and the unique facts and circumstances applicable to each particular agreement. To date, the Company has not made any payments related to these indemnification agreements.

The Company warrants certain of its products to be free of defects generally for a period of three years. The Company estimates its warranty costs based on historical warranty claim experience and includes such costs in cost of net revenues. Warranty costs were not material for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021.

The Company is not a party to any legal proceeding that the Company believes is likely to have a material adverse effect on its condensed consolidated financial position or results of operations. From time to time the Company may be subject to legal proceedings and claims in the ordinary course of business. These claims, even if not meritorious, could result in the expenditure of significant financial resources and diversion of management efforts.

Note 6.7. Business Segments, Concentration of Credit Risk and Significant Customers

The Company determined its reporting units in accordance with ASC 280, Segment Reporting (ASC 280). Management evaluates a reporting unit by first identifying its operating segments under ASC 280. The Company then evaluates each operating segment to determine if it includes one or more components that constitute a business. If there are components within an operating segment that meet the definition of a business, the Company evaluates those components to determine if they must be aggregated into one or more reporting units. If applicable, when determining if it is appropriate to aggregate different operating segments, the Company determines if the segments are economically similar and, if so, the operating segments are aggregated.

Management has determined that the Company has 1one consolidated operating segment. The Company’s reporting segment reflects the manner in which its chief operating decision maker reviews results and allocates resources. The Company’s reporting segment meets the definition of an operating segment and does not include the aggregation of multiple operating segments.

The Company recognized revenue from shipments of product, licensing of its technologies and performance of services to customers by geographical location as follows (in thousands):

	Three Months Ended				Three Months Ended					Nine Months Ended
	March 31,				September 30,					September 30,
	2022		2021		2022		2021			2022		2021
North America	$	2,375	$	55	$	1,918	$	984		$	7,158	$	1,145
Hong Kong		290		475		447		1,027			1,328		2,057
Taiwan		312		565		131		(2	)		646		586
Japan		293		—		368		—			905		—
Rest of world		133		6		430		9			944		28
Total net revenue	$	3,403	$	1,101	$	3,294	$	2,018		$	10,981	$	3,816

	Three Months Ended		Three Months Ended		Nine Months Ended
	March 31,		September 30,		September 30,
	2022	2021	2022	2021	2022	2021
Customer A	37%	*	24%	*	24%	*
Customer B	24%	*	22%	14%	28%	*
Customer C	*	41%	14%	45%	12%	48%
Customer D	*	51%	*	*	*	15%
Customer E			*	33%	*	18%

~~NaN~~As of September 30, 2022, two customers accounted for ~~67%~~60% of accounts receivable, asand the Company recorded a provision for doubtful accounts of ~~March 31, 2022. NaN~~$683,000 against one of the customer’s receivables. Three customers accounted for 96% of accounts receivable as of December 31, 2021.

The Company determines deferred tax assets and liabilities based upon the differences between the financial statement and tax bases of the Company’s assets and liabilities using tax rates in effect for the year in which the Company expects the differences to affect taxable income. A valuation allowance is established for any deferred tax assets for which it is more likely than not that all or a portion of the deferred tax assets will not be realized.

The Company files U.S. federal and state and foreign income tax returns in jurisdictions with varying statutes of limitations. All tax returns from 2015 to 2020 may be subject to examination by the Internal Revenue Service, California and other states. Returns filed in foreign jurisdictions may be subject to examination for the years 2011 to 2020. As of ~~March 31,~~September 30, 2022, the Company has 0tnot recorded any liability for unrecognized tax benefits related to uncertain tax positions.

In 2010, the Company adopted the 2010 Equity Incentive Plan and later amended it in 2014, 2017 and 2018 (the Amended 2010 Plan). The Amended 2010 Plan was terminated in August 2019 and remains in effect as to outstanding equity awards granted prior to the date of expiration. ~~NaN~~No new awards may be made under the Amended 2010 Plan.

In August 2019, the Company’s stockholders approved the 2019 Stock Incentive Plan (the 2019 Plan), and it replaced the Amended 2010 Plan. The 2019 Plan authorizes the board of directors or the compensation committee of the board of directors to grant a broad range of awards including stock options, stock appreciation rights, restricted stock, performance-based awards, and restricted stock units. Under the 2019 Plan, 182,500 shares were initially reserved for issuance.

In November 2021, in connection with the approval of the Arrangement, the Company’s stockholders approved an amendment increasing the number of shares reserved for issuance under the 2019 Plan by 3,106,937 shares.

Under the 2019 Plan, the term of all incentive stock options granted to a person who, at the time of grant, owns stock representing more than 10% of the voting power of all classes of the Company’s stock may not exceed five years. The exercise price of stock options granted under the 2019 Plan must be at least equal to the fair market value of the shares on the date of grant. Generally, awards under the 2019 Plan will vest over a three to four-year period, and options will have a term of 10 years from the date of grant. In addition, the 2019 Plan provides for automatic acceleration of vesting for options granted to non-employee directors upon a change of control of the Company.

In connection with the Arrangement, the Company assumed the Peraso Technologies Inc. 2009 Share Option Plan (the 2009 Plan) and all outstanding options granted pursuant to the terms of the 2009 Plan. Each outstanding, unexercised and unexpired option under the 2009 Plan, whether vested or unvested, was assumed by the Company and converted into options to purchase shares of the Company’s common stock and became exercisable by the holder of such option in accordance with its terms, with (i) the number of shares of common stock subject to each option multiplied by the Exchange Ratio and (ii) the per share exercise price upon the exercise of each option divided by the Exchange Ratio. In connection with the Arrangement, 0no further awards will be made under the 2009 Plan.

The 2009 Plan, the Amended 2010 Plan and the 2019 Plan are referred to collectively as the “Plans.”

The Company reflected compensation costs of $3.4 million and $3.5 million related to the vesting of stock options during the nine-month periods ended September 30, 2022 and 2021, respectively. At ~~March 31,~~September 30, 2022, the unamortized compensation cost was approximately ~~$11.4~~$8.9 million related to stock options and is expected to be recognized as expense over a weighted average period of approximately 32.3 years. The Company reflected compensation costs of $1.0 million and zero related to the vesting of restricted stock options during the nine months ended September 30, 2022 and 2021, respectively. The unamortized compensation cost at ~~March 31,~~September 30, 2022 was ~~$0.2~~$2.3 million related to restricted stock units and is expected to be recognized as expense over a weighted average period of approximately ~~1.6~~2.3 years.

~~For the three months ended March 31, 2022 and 2021, there were 0 excess tax benefits associated with the exercise of stock options due to the Company’s historical loss positions.~~

There were 0no stock options granted or exercised during the ~~three~~nine months ended ~~March 31, 2022~~September 30, 2022. There were no stock options granted and stock options were exercised for 452 shares of common stock during the nine months ended September 30, 2021.

The term of all incentive stock options granted to a person who, at the time of grant, owns stock representing more than 10% of the voting power of all classes of the Company’s stock may not exceed five years. The exercise price of stock options granted under the 2019 Plan must be at least equal to the fair market value of the shares on the date of grant. Generally, options granted under the 2019 Plan will vest over a three to four-year period and have a term of 10 years from the date of grant. In addition, the 2019 Plan provides for automatic acceleration of vesting for options granted to non-employee directors upon a change of control (as defined in the 2019 Plan) of the Company.

The following table summarizes the activity in the shares available for grant under the Plans during the ~~three~~nine months ended ~~March 31,~~September 30, 2022 (in thousands, except exercise price):

	Options Outstanding								Options Outstanding
				Weighted								Weighted
				Average		Shares						Average
	Number of			Exercise		Available			Number of			Exercise
	Shares			Prices		for Grant			Shares			Prices
Balance as of December 31, 2021		1,558		$	3.49		3,024			1,558		$	3.49
Options cancelled		(13	)	$	10.98		—			(13	)	$	10.98
Balance as of March 31, 2022		1,545		$	3.43		3,024			1,545		$	3.43
RSUs granted							(1,511	)		—		$	-
RSUs cancelled and returned to the Plan							43			—		$	-
Options cancelled							—			(8	)	$	2.63
Balance as of June 30, 2022							1,556			1,537		$	3.43
RSUs granted							(67	)		—		$	-
RSUs cancelled and returned to the Plan							103			—		$	-
Options cancelled							—			(23	)	$	2.57
Balance as of September 30, 2022							1,592			1,514		$	3.39

A summary of RSU activity under the Plans is presented below (in thousands, except for fair value):

				Weighted					Weighted
				Average					Average
	Number of			Grant-Date		Number of			Grant-Date
	Shares			Fair Value		Shares			Fair Value
Non-vested shares as of December 31, 2021		88		$	4.84		88		$	4.84
Vested		(13	)	$	3.70		(13	)	$	3.70
Non-vested shares as of March 31, 2022		75		$	5.67		75		$	5.67
Granted							1,511			—
Vested							(271	)	$	2.49
Cancelled							(12	)		—
Non-vested shares as of June 30, 2022							1,303		$	2.28
Granted							67			—
Vested							(38	)	$	2.45
Cancelled							(103	)		—
Non-vested shares as of September 30, 2022							1,229		$	2.27

The following table summarizes significant ranges of outstanding and exercisable options as of ~~March 31,~~September 30, 2022 (in thousands, except contractual life and exercise price):

	Options Outstanding						Options Exercisable						Options Outstanding						Options Exercisable
			Weighted												Weighted
			Average												Average
			Remaining		Weighted				Weighted						Remaining		Weighted				Weighted
			Contractual		Average				Average		Aggregate				Contractual		Average				Average		Aggregate
	Number		Life		Exercise		Number		Exercise		Intrinsic		Number		Life		Exercise		Number		Exercise		Intrinsic
Range of Exercise Price	Outstanding		(in Years)		Price		Exercisable		Price		value		Outstanding		(in Years)		Price		Exercisable		Price		value
$1.57 - $14.99		1,534		8.18	$	2.65		621	$	2.50	$	84		1,502		7.89	$	2.65		865	$	2.52	$	10
$15.00 - $25.59		4		1.49	$	15.00		4	$	15.00	$	—		5		0.98	$	17.12		5	$	17.12	$	—
$25.60 - $143.99		1		2.42	$	50.00		1	$	50.00	$	—		1		3.89	$	101.27		1	$	101.27	$	—
$144.00 - $409.99		5		4.40	$	144.00		5	$	144.00	$	—		5		3.74	$	144.00		5	$	144.00	$	—
$410.00 - $924.00		1		3.00	$	410.00		1	$	410.00	$	—		1		1.95	$	410.00		1	$	410.00	$	—
$1.57 - $924.00		1,545		8.15	$	3.43		632	$	4.42	$	84		1,514		7.85	$	3.39		877	$	3.81	$	10

As of ~~March 31,~~September 30, 2022, the Company had the following warrants outstanding (share amounts in thousands):

On November 30, 2020, the Company entered into a loan agreement (the SRED Financing) to raise funds against the Company’s present and after acquired personal property. On February 5, 2021, March 5, 2021 and September 17, 2021 the Company raised additional funds from the second, third and fourth draws under the SRED financing of $274,715 (CDN$350,000), $274,715 (CDN$350,000) and $745,655 (CDN$950,000) respectively, totaling year to date gross proceeds of $1,295,085 (CDN$1,650,000) net of financing fees of $32,770 (CDN$41,750). ~~The loan agreement for all tranches~~Each borrowing carried an interest rate of 1.6% per month, compounded monthly (20.98%). The ~~loan~~SRED financing was sanctioned against the Company’s SRED tax credit refund.

The first, second and third draws, including interest of $136,900 (CDN$174,417), were repaid through proceeds from the Company’s tax credit refund of $1,093,230 (CDN$1,392,831) received in August 2021, and the balance of $184,558 (CDN$ 235,132) was paid from the fourth draw. The remaining loan balance, including interest, of $816,964 (CDN$1,044,177) was repaid on December 16, 2021.

Interest expense of ~~$513,438~~$870,212 for the three months ended ~~March 31,~~September 30, 2021 consisted of i) ~~$348,134~~$625,913 of amortization of debt discount, ii) $212,971 of interest expense on convertible debt, which was outstanding and ~~$120,950~~retired in 2021, and iii) $31,328 of interest expense on the SRED financing. Interest expense of $2,170,059 for the nine months ended September 30, 2021 consisted of i) $1,510,368 of amortization of debt discount, ii) $522,274 of interest expense on convertible debt, which was outstanding and ~~ii) $44,354~~retired in 2021, and iii) $137,417 of interest expense on the SRED financing.

A family member of one of the Company’s executive officers serves as a consultant to the Company. During the nine months ended September 30, 2022 and 2021, the Company paid approximately $126,800 and $153,100, respectively, to the consultant. Additionally, a family member of one of the Company’s executive officers is an employee of the Company. During the nine months ended September 30, 2022, the Company paid approximately $127,500 to the employed family member, which includes the aggregate grant date fair value, as determined pursuant to FASB ASC Topic 718, of an RSU awarded in April 2022. During the nine months ended September 30, 2021, the Company paid approximately $69,000 to the employed family member.

On August 5, 2022, the Company entered into a Technology License and Patent Assignment Agreement (the Intel Agreement) with Intel Corporation (Intel), pursuant to which Intel: (i) licensed from the Company, on an exclusive basis, certain software and technology assets related to the Company’s Stellar packet classification intellectual property, including its graph memory engine technology, and any roadmap variant, in the form existing as of the date of the Agreement (the Licensed Technology); (ii) acquired from the Company certain patent applications and patents owned by the Company; and (iii) assumed a professional services agreement, dated March 24, 2020, between Fabulous Inventions AB (Fabulous) and the Company (the Fabulous Agreement), pursuant to which, among other things, the Company licensed from Fabulous certain technology incorporated into the Licensed Technology.

As consideration for the Company to enter into the Agreement, Intel agreed to pay the Company $3,062,500 at the closing of the transaction (the Closing) and $437,500 (the Holdback) upon the satisfaction by the Company, as mutually agreed upon by the parties in good faith, of certain release criteria set forth in the Agreement relating to various due diligence activities of Intel regarding the Licensed Technology (the Release Criteria). Intel and the Company agreed to work together in good faith so as to ensure that the Release Criteria is satisfied by the Company no later than six months following the Closing.

The Company determined that the license and asset sale did not qualify as a sale of a business, but as a sale of a non-financial asset, with the resultant gain recorded as income from operations in accordance with ASC 610-20, Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets. During the three months ended September 30, 2022, the Company recognized a $2.6 million gain on this transaction, net of transaction costs, which was recorded as a reduction of operating expenses in the condensed consolidated statements of operations and comprehensive loss. Any gain related to the Holdback will be recorded when the Release Criteria have been satisfied, which is expected to be within six months of August 5, 2022.

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the accompanying condensed consolidated financial statements and notes included in this report. This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which include, without limitation, statements about the market for our technology, our strategy, competition, expected financial performance and capital raising effort., the impacts of COVID-19 on our business, the effects of the Russia/Ukraine conflict, and inflation, which could cause customers to delay or reduce purchases of our products or delay payments to us, which would adversely affect our financial results, including cash flows, and other aspects of our business identified in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2022 and in other reports that we file from time to time with the Securities and Exchange Commission. Any statements about our business, financial results, financial condition and operations contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “expects,” “intends,” “plans,” “projects” or similar expressions are intended to identify forward-looking statements. Our actual results could differ materially from those expressed or implied by these forward-looking statements as a result of various factors, including the risk factors described under Item 1A of our annual report on Form 10-K for the year ended December 31, 2021 and the risk factors described below under Item 1A of this Form 10-Q. We undertake no obligation to update publicly any forward-looking statements for any reason, except as required by law, even as new information becomes available or events occur in the future.

We were formerly known as MoSys, Inc. (MoSys) and were incorporated in California in 1991 and reincorporated in Delaware in 2000. On September 14, 2021, we and our subsidiaries, 2864552 Ontario Inc. and 2864555 Ontario Inc., entered into an Arrangement Agreement (the Arrangement Agreement) with Peraso Technologies Inc. (Peraso Tech), a corporation existing under the laws of the province of Ontario, to acquire all of the issued and outstanding common shares of Peraso Tech (the Peraso Shares), including those Peraso Shares to be issued in connection with the conversion or exchange of secured convertible debentures and common share purchase warrants of Peraso Tech, as applicable, by way of a statutory plan of arrangement (the Arrangement) under the Business Corporations Act (Ontario). On December 17, 2021, following the satisfaction of the closing conditions set forth in the Arrangement Agreement, the Arrangement was completed and the Company changed its name to “Peraso Inc.” and began trading on the Nasdaq Stock Market under the symbol “PRSO.”

For accounting purposes, the legal subsidiary, Peraso Tech, has been treated as the accounting acquirer and we, the legal parent, have been treated as the accounting acquiree. The transaction has been accounted for as a reverse acquisition in accordance with Financial Accounting Standards Board Accounting Standards Codification (ASC) No. 805, Business Combinations ~~(ASC 805)~~. Accordingly, the financial condition and results of operations discussed herein are a continuation of Peraso Tech’s financial results prior to December 17, 2021 and exclude the financial results of us prior to December 17, 2021. See Note 2 to the condensed consolidated financial statements for additional disclosure.

Our strategy and primary business objective is to be a profitable, IP-rich, fabless semiconductor company offering integrated circuits (ICs), modules and related non-recurring engineering services. We specialize in the development of mmWave semiconductors, primarily in the 60 GHz spectrum band for 802.11ad/ay compliant devices and in the 28/39 GHz spectrum bands for 5G-compliant devices. We derive our revenue from selling semiconductor devices, as well as modules based on using those mmWave semiconductor devices. We have pioneered a high-volume mmWave production test methodology using standard low cost production test equipment. It has taken us several years to refine performance of this production test methodology, and we believe this places us in a leadership position in addressing operational challenges of delivering mmWave products into high-volume markets. During 2021, we augmented our business model and began selling complete mmWave modules. The primary advantage provided by a module is the silicon and the antenna are integrated into a single device. A differentiating characteristic of mmWave technology is that the radio frequency amplifiers must be as close as possible to the antenna to minimize loss, and, by providing a module, we can guarantee the performance of the amplifier/antenna interface.

We also ~~acquired~~have a memory product line, marketed under the Accelerator Engine name, ~~and that comprises~~which includes our Bandwidth ~~Engine and Programmable HyperSpeed~~ Engine IC products, which integrate our proprietary, 1T-SRAM high-density embedded memory and a highly-efficient, serial interface protocol resulting in a monolithic memory IC solution optimized for memory bandwidth and transaction access performance. As we are not developing new memory products, from a product development perspective, we continue to leverage our current technologies and core competencies to expand our product offerings without incurring significant additional research and development (R&D) expenses.

We incurred net losses of approximately ~~$6.8~~$16.6 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and ~~$10.8~~$10.9 million for the year ended December 31, 2021, and we had an accumulated deficit of approximately ~~$124.0~~$133.8 million as of ~~March 31,~~September 30, 2022. These and prior year losses have resulted in significant negative cash flows and historically have required us to raise substantial amounts of additional ~~capital during this period.~~

capital. We expect to continue to incur operating losses and will need to increase revenues substantially beyond levels that we have attained in the past in order to generate sustainable operating profit and sufficient cash flows to continue doing business without raising additional capital from time to time.

The global outbreak of the coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization and a national emergency by the U.S. government in March 2020. This has negatively affected the U.S. and global economy, disrupted global supply chains, significantly restricted travel and transportation, resulted in mandated closures and orders to “shelter-in-place” and created significant disruption of the financial markets. The full extent of the COVID-19 impact on our operational and financial performance will depend on future developments, including the duration and spread of the pandemic and related actions taken by the U.S. and foreign government agencies to prevent disease spread, all of which are uncertain, out of our control, and cannot be predicted.

Since March 2020, certain jurisdictions in which we operate have issued ’shelter-in-place” orders. We have complied with these orders and, when such orders were in place, minimized business activities at our facilities. We have implemented a teleworking policy for our employees and contractors to reduce on-site activity.

We ~~remain diligent in continuing to identify and manage risks to our business given the changing uncertainties related to COVID-19. The ultimate impact of~~believe that as the COVID-19 pandemic evolves, the direct and indirect impacts of the pandemic on global macroeconomic conditions, as well as conditions specific to us, are becoming more difficult to isolate or quantify. In addition, these direct and indirect factors can make it difficult to isolate and quantify the portion of our costs that are a direct result of the pandemic and costs arising from factors that may have been influenced by the pandemic, such as supply chain constraints, rising inflation, and recessionary fears. We expect these factors and their effects on our ~~business and results of~~ operations ~~is uncertain and difficult~~may persist for a longer period, even after the COVID-19 pandemic has subsided. We continue to ~~predict, and we are~~ closely ~~monitoring~~monitor impacts, especially to customer programs and our supply chain.We are working internally and with suppliers on programs (i.e., new production flows, etc.) to allow us to increase our peak throughput to better handle unplanned disruptions to our supply chain. To date, we have not experienced a material impact on our cash flows, liquidity, capital resources, cash requirements, financial position, or results of operations, attributable to the global semiconductor supply chain disruption and inflation. We have experienced increased prices from our suppliers, and, for certain products, we have increased prices to our customers to mitigate the impacts, although to date in 2022 the impacts of these price increases have been minimal. We have and continue to experience longer lead times for certain components used to manufacture our products, and, therefore, and, in response, we have identified second and third sources for certain components used in our module products. Also, we have increased lead times for our customers. We have not experienced any issues over our product quality and product development activities, as we do not rely significantly on outside vendors to manage and perform these activities for us. We currently have not identified any current impacts of the supply chain disruption and inflation that will affect our future results, and it is difficult to differentiate whether higher prices are due to supply chain disruption, inflation or a mix of both.

While we believe that our operations personnel are currently in a position to meet expected customer demand levels in the coming quarters, we recognize that unpredictable events could create difficulties in the months ahead. We may not be able to address these difficulties in a timely manner, which could negatively impact our business, results of operations, financial condition and cash flows.

The continued spread of COVID-19 has also led to disruption and volatility in the global capital markets. ~~Our ability~~The Russian invasion of Ukraine in February 2022 has led to ~~raise~~further economic disruptions. Mounting inflationary cost pressures and recessionary fears have negatively impacted the global economy. During the third quarter of 2022, the U.S. Federal Reserve continued to aggressively address elevated inflation by increasing interest rates. The U.S. Federal Reserve increased interest rates by 75 basis points in each of its meetings held in July, September and November 2022, with an additional ~~capital to support operations in the future may be impacted, and~~increase forecasted for December 2022 as inflation remains elevated. Given current market conditions, we may be unable to access the capital markets, and additional capital may only be available to us on terms that could be significantly detrimental to our existing stockholders and to our ~~business~~. business.

For additional information on risks that could impact our future results, please refer to “Risk Factors” in Part II, Item 1A. of this quarterly report on Form 10-Q.

Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied. The majority of our contracts have a single performance obligation to transfer products. Accordingly, we recognize revenue when title and risk of loss have been transferred to the customer, generally at the time of shipment of products. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products and is generally based upon a negotiated, formula, list or fixed price. We sell our products both directly to customers and through distributors generally under agreements with payment terms typically 60 days or less.

We may record an estimated allowance, at the time of shipment, for future returns and other charges against revenue consistent with the terms of sale.

Our licensing contracts typically provide for royalties based on the licensee’s use of our memory technology in its currently shipping commercial products. We estimate its royalty revenue in the calendar quarter in which the licensee uses the licensed technology. Payments are received in the subsequent quarter. We also generate revenue from licensing

our technology. We recognize license fees as revenue at the point of time when the control of the license has been transferred and we have no continuing performance obligations to the customer.

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with ~~GAAP.~~accounting principles generally accepted in the United States (GAAP). The preparation of these condensed consolidated financial statements requires us to make certain estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis we make these estimates based on our historical experience and on assumptions that we consider reasonable under the circumstances. Actual results may differ from these estimates and reported results could differ under different assumptions or conditions. Our significant accounting policies and estimates are disclosed in Note 1 of the “Notes to Consolidated Financial Statements” in our annual report on Form 10-K for the year ended December 31, 2021. As of ~~March 31,~~September 30, 2022, there have been no material changes to our significant accounting policies and estimates.

We previously classified intangible asset amortization expense related to the developed technology and customer relationships intangibles within research and development expenses (R&D) in our condensed consolidated statements of operations and comprehensive loss. Amortization expense on the developed technology intangible asset is now classified within cost of net revenue, and amortization expense on customer relationships is now classified in selling, general and administrative expenses (SG&A). Prior period amounts have been conformed to the current period presentation. See Notes 1 and 5 to the condensed consolidated financial statements for a discussion of the reclassifications.

	March 31,						Change				September 30,						Change
	2022			2021			2021 to 2022				2022			2021			2021 to 2022
	(dollar amounts in thousands)										(dollar amounts in thousands)
Product -three months ended	$	3,204		$	1,051		$	2,153	205	%	$	3,060		$	1,389		$	1,671	120	%
Percentage of total net revenue		94	%		95	%						93	%		69	%
Product -nine months ended											$	10,384		$	3,016		$	7,368	244	%
Percentage of total net revenue												95	%		79	%

The following table details revenue by product category for the three and nine months ended September 30, 2022 (in thousands):

Product revenue increased for the three months ended ~~March 31,~~September 30, 2022 compared with the same period of 2021 primarily due to the increase in the memory IC sales volumes due to the acquisition of this product line in December 2021 and the increase of the mmWave module sales volumes due to the roll-out of this product line in August 2021. As discussed elsewhere in this Report, for reverse-acquisition accounting purposes, Peraso Tech, was treated as the accounting acquirer, and MoSys was treated as the accounting acquiree. Accordingly, the results of operations discussed herein are a continuation of Peraso Tech’s historical financial results and exclude the results of operations of MoSys prior to December 17, 2021. The increase in memory IC sales volumes, which was due to the acquisition of this product line, resulted in a $1.7 million increase to revenue for the three months ended September 30, 2022, as compared to the prior year due to a 100% increase in sales volumes in 2022. Additionally, we began selling our mmWave module products during the second half of 2021, representing a 119% increase in sales volumes and an additional $0.5 million in revenue for the three months ended September 30, 2022. We have initiated price increases on certain of our module products in 2022. However, through September 30, 2022, we had not realized any material increase in revenue as a result of those price increases.

Product revenue increased for the nine months ended September 30, 2022 compared with the same period of 2021 primarily due to ~~a full quarter contribution of revenues from our~~increase in the memory IC sales volumes due to the acquisition of this product line in December 2021 and the increase of mmWave module sales volumes due to the roll-out of this new product line in the second half of 2021. The increase in memory IC sales volumes resulted in a $5.5 million increase in revenues for the nine months ended September 30, 2022 as compared to prior year due to a 100% increase in sales volumes. Additionally, we began selling our mmWave module products during the second half of 2021 and realized a 100% increase in sales volumes in 2022, which contributed $2.8 million of increased revenue for the nine months ended September 30, 2022. We initiated price increases on certain of our module products in 2022. However, through September 30, 2022, we had not realized any material increase in revenue as a result of those price increases. These revenue increases were partially offset by a decrease of $1.0 million in sales of our mmWave IC products due to a 39% reduction in volumes shipped during the nine months ended September 30, 2022, compared with the same period in 2021. Although, stand-alone mmWave IC volumes decreased, shipments of our mmWave modules that include the mmWave ICs have increased, and each module ~~products.~~we ship includes our mmWave ICs. We ~~commenced selling~~began shipping modules, which include our ~~module products~~mmWave IC in a chipset with an antenna, as it provides an integrated solution that we believe can shorten our revenue cycle by enabling our customers to accelerate time to production. In addition, we generate higher revenue from the ~~second quarter~~sale of ~~2021.~~ modules compared to sales of stand-alone ICs. Going forward, we expect sales of our mmWave ICs on a stand-alone basis to decline as a percentage of total product revenue, as we expect sales of our modules to be our primary source of revenue growth.

We expect revenues to increase for the remainder of 2022 and in ~~2022,~~2023, as we expect increased sales of our mmWave products, including the benefits of price increases implemented in 2022, and will experience a full-year contribution of revenues from our memory products. We expect sales of our memory products to increase from a volume and revenue perspective over the next 12 months. However, our memory products have been in production since 2014, and, given that we have not developed new products, the long-term outlook for these products is uncertain. We have implemented modest price increases on our memory products that we expect to begin taking effect in the first half of 2023, and we expect these price increases to contribute to revenue growth in 2023. We expect sales of our mmWave modules to increase from a volume and revenue perspective over the next 12 months, as our primary sales focus is on obtaining new module customers. Our lead module customer has provided purchase orders and forecasts, which support our expected increases in volume and revenue from module shipments. In addition, we expect meaningful contribution in 2023 from price increases that we implemented in 2022 on our module products.

	March 31,						Change				September 30,						Change
	2022			2021			2021 to 2022				2022			2021			2021 to 2022
	(dollar amounts in thousands)										(dollar amounts in thousands)
License and other -three months ended	$	199		$	50		$	149	298	%
Royalty and other -three months ended											$	234		$	629		$	(395	)	(63	)%
Percentage of total net revenue		6	%		5	%						7	%		31	%
Royalty and other -nine months ended											$	597		$	800		$	(203	)	(25	)%
Percentage of total net revenue												5	%		21	%

~~License~~Royalty and other includes royalty, non-recurring engineering, ~~(NRE),~~ services and licenses revenues. The ~~increase~~decrease in ~~license~~royalty and other revenue for the three and nine months ended ~~March 31,~~September 30, 2022 compared with the same period of 2021 was primarily due to a decrease in non-recurring engineering services revenue related to our mmWave technology, partially offset by full ~~quarter contribution~~three and nine-month contributions of royalty revenues from licensees of our memory technology. As the reverse acquisition occurred on December 17, 2021, the results of operations for the three and nine months ended September 30, 2021 exclude all royalty revenue from licensing of memory technology.

	March 31,						Change				September 30,						Change
	2022			2021			2021 to 2022				2022			2021			2021 to 2022
	(dollar amounts in thousands)										(dollar amounts in thousands)
Cost of net revenue -three months ended	$	1,590		$	619		$	971	157	%	$	2,000		$	919		$	1,081	118	%
Percentage of total net revenue		47	%		56	%						61	%		46	%
Cost of net revenue -nine months ended											$	6,747		$	1,973		$	4,774	242	%
Percentage of total net revenue												61	%		52	%

	March 31,						Change				September 30,						Change
	2022			2021			2021 to 2022				2022			2021			2021 to 2022
	(dollar amounts in thousands)										(dollar amounts in thousands)
Gross profit -three months ended	$	1,813		$	482		$	1,331	276	%	$	1,294		$	1,099		$	195	18	%
Percentage of total net revenue		53	%		44	%						39	%		54	%
Gross profit -nine months ended											$	4,234		$	1,843		$	2,391	130	%
Percentage of total net revenue												39	%		48	%

Cost of net revenue is primarily comprised of direct and indirect costs related to the sale of our ~~products.~~products, including amortization of intangible assets and depreciation of production-related fixed assets.

Cost of net revenue increased for the three and nine months ended ~~March 31,~~September 30, 2022 when compared with the same period in 2021, primarily due to increased shipment volumes of our LineSpeed and Bandwidth Engine IC and mmWave module products. Our module products have higher cost of goods sold per unit and generate lower gross profit margin than our IC products.

Gross profit ~~decreased~~increased for the three and nine months ended ~~March 31,~~September 30, 2022 compared with the same period of 2021 due to the increased product shipments. The decrease in our gross profit margin for the three and nine months ended September 30, 2022 compared with the prior year periods was primarily attributable to the increased volume shipments of our mmWave modules, which carry lower gross margins than our IC products.

	March 31,						Change				September 30,						Change
	2022			2021			2021 to 2022				2022			2021			2021 to 2022
	(dollar amounts in thousands)										(dollar amounts in thousands)
R&D -three months ended	$	6,003		$	2,787		$	3,216	115	%	$	4,509		$	2,696		$	1,813	67	%
Percentage of total net revenue		176	%		253	%						137	%		134	%
Research and development -nine months ended											$	15,636		$	8,375		$	7,261	87	%
Percentage of total net revenue												142	%		219	%

Our R&D expenses include costs related to the development of our products. We expense R&D costs as they are incurred.

The increase for the three months ended ~~March 31,~~September 30, 2022 compared with the same period of 2021 was primarily due to the inclusion of a full ~~quarter~~three months of expenses of $0.9 million related to the former operations of MoSys, amortization of acquired intangible assets infrom the ~~first quarter~~reverse acquisition of $0.5 million, which closed on December 17, 2021, for the three and nine months ended September 30, 2022 and recognition of $0.5 million of Canadian government refundable tax credits and wage and rent subsidies induring the first ~~quarter~~nine months of 2021 that reduced operating expenses.

The increase for the nine months ended September 30, 2022 compared with the same period of 2021 was primarily due to the inclusion of a full nine months of expenses of $3.8 million related to the former operations of MoSys, amortization of acquired intangible assets from the reverse acquisition of $1.5 million, which closed on December 17, 2021, and recognition of $1.8 million of Canadian government refundable tax credits and wage and rent subsidies during the first nine months of 2021 that reduced operating expenses.

We expect that total ~~research and development~~R&D expenses will increase in 2022 compared with 2021, as we will include the operations ofrelated to MoSys and ~~increase~~increased development of our mmWave products and ~~technologies.~~technologies, including our new 5G mmWave products. In addition, we do not expect to receive any Canadian government subsidies in 2022 that would reduce our R&D expenses.

	March 31,						Change				September 30,						Change
	2022			2021			2021 to 2022				2022			2021			2021 to 2022
	(dollar amounts in thousands)										(dollar amounts in thousands)
SG&A -three months ended	$	2,546		$	1,307		$	1,239	95	%	$	3,353		$	1,746		$	1,607	92	%
Percentage of total net revenue		75	%		119	%						102	%		87	%
SG&A -nine months ended											$	8,938		$	4,852		$	4,086	84	%
Percentage of total net revenue												81	%		127	%

~~Selling, general and administrative (SG&A),~~SG&A expenses consist primarily of personnel and related overhead costs for sales, marketing, finance, human resources and general ~~management.~~

The increase for the three months ended ~~March 31,~~September 30, 2022 compared with the same period of 2021 was primarily due to the inclusion of $1.4 million of expense, which represented the inclusion of a full ~~quarter~~three months of expenses related to related to the former operations of ~~MoSys.~~MoSys, as a result of the reverse acquisition that closed in December 2021. The increases were partially offset by a $0.5 million decrease in costs incurred during the three months ended September 30, 2021 related to the reverse acquisition.

The increase for the three and nine months ended September 30, 2022 compared with the same period of 2021 was primarily due to the inclusion of $4.2 million of expense, which represented the inclusion of a full nine months of expenses related to related to the former operations of MoSys, and recognition of Canadian government wage and rent subsidies during the first nine months of 2021 that reduced operating expenses. The increases were partially offset by a $1.1 million decrease in costs incurred during the nine months ended September 30, 2021 related to the reverse acquisition.

We expect that total SG&A expenses will increase in 2022 compared with 2021, as we will include the operations related to MoSys, and, in addition, we do not expect to receive any Canadian government subsidies in 2022 that would reduce our R&D expenses.

Interest expense incurred during the ~~quarter~~nine months ended ~~March 31,~~September 30, 2021 related to our convertible debt and loans payable, which were repaid and/or converted into equity during 2021.

As of ~~March 31,~~September 30, 2022, we had cash, cash equivalents and investments of ~~$12.2~~$3.9 million and working capital of ~~$13.7~~$9.0 million. We believe that cash generated from our liquidity sources will be sufficient to meet both our short-term and long-term working capital and capital expenditure needs for at least the next twelve months.

Net cash used in operating activities was ~~$5.7~~$13.4 million for the first ~~three~~nine months of 2022, which primarily resulted from our net loss of ~~$6.8~~$17.8 million and ~~$1.0~~$3.1 million in net changes in assets and liabilities, partially offset by non-cash charges of ~~$0.8~~$2.3 million of depreciation and amortization, ~~$1.2~~$4.4 million of stock based compensation, $0.7 million of allowance for doubtful accounts and a $0.1 million

~~loss on disposal of property and equipment.~~ for other non-cash items. The changes in assets and liabilities primarily related to the timing of accounts receivable collections, purchases of inventory and other vendor payables and prepayments.

Net cash used in operating activities was ~~$1.3~~$7.1 million for the first ~~three~~nine months of 2021, which primarily resulted from our net loss of ~~$4.2~~$13.4 million and a $0.1 million other non-cash items, which was ~~partially~~ offset by ~~$0.9 million in net changes in assets and liabilities and~~ non-cash charges of ~~$1.2~~$3.5 million of stock-based compensation, ~~$0.3~~$0.8 million of depreciation and amortization expenses, ~~$0.3~~$1.5 million amortization of debt discount, and ~~$0.2~~$0.6 million of accrued interest. The changes in assets and liabilities primarily related to the timing of accounts receivable collections and other vendor payables and prepayments.

Net cash provided by investing activities of ~~$3.6~~$10.4 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 represented ~~$4.2~~$11.5 million in proceeds from maturities of short-term investments, partially offset by $0.5 million purchases of short and long-term investments and ~~$0.1~~$0.6 million of purchases of property and equipment. Net cash used in investing activities for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 represented approximately ~~$9,000~~$57,000 of purchases of property and ~~equipment.~~equipment and $95,000 of intangible assets.

Net cash used in financing activities for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 consisted of taxes paid to net share settle equity awards.

Net cash provided by financing activities for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 consisted of net proceeds received from an unsecured loan.

Our future liquidity and capital requirements are expected to vary from quarter-to-quarter, depending on numerous factors, including:

~~Our primary need for liquidity is to fund working capital requirements~~As of September 30, 2022, we had outstanding accounts receivable of $1.6 million, which included $0.7 million collectible from WeLink Communications LLC (WeLink), a customer that represented 28% of our ~~businesses, capital expenditures and~~revenue for ~~general corporate purposes.~~ ~~We expect our cash expenditures to exceed receipts in 2022, as we do not expect our revenues will be sufficient to offset our working capital requirements. We~~ ~~incurred a net loss of approximately $6.8 million for~~the nine months ended September 30, 2022. During the three months ended ~~March~~September 30, 2022, we had $1.1 million of product shipments to WeLink for which the revenue recognition criteria under ASC 606 had not been met. Accordingly, we deferred the cost of net revenue of $0.6 million associated with these shipments, and the amount deferred has been presented as deferred cost of net revenue in our condensed consolidated balance sheets.

Historically, we have collected all amounts due from WeLink, although generally not within contractual payment terms. As of September 30, 2022, we determined that an allowance for doubtful accounts of $0.7 million was warranted on the outstanding receivables from WeLink due to the delays in collecting from WeLink. The longer collection times have negatively impacted our liquidity and working capital. No assurances can be given that we will be able to collect the receivables from WeLink in a timely manner, if at all. Recognition of additional bad debt expense, further delays in collecting accounts receivable or our inability to recognize the deferred cost of net revenues could have a material adverse effect on our financial condition, cash flows and results of operations.

We incurred net losses of approximately $17.8 million for the nine months ended September 30, 2022 and $10.9 million for the year ended December 31, ~~2022~~2021, and we had an accumulated deficit of approximately ~~$124.0~~$135.0 million as of ~~March 31,~~September 30, 2022. These and prior year losses have resulted in significant negative cash flows and have required us to raise substantial amounts of additional ~~capital during this period.~~ capital. To date, we have primarily financed our operations through multiple ~~equity~~ offerings ~~issuances~~of common stock and issuance of convertible ~~debentures, utilization~~notes and loans to investors and affiliates.

We expect to continue to incur operating losses for the foreseeable future as we continue to secure new customers for and continue to invest in the development of ~~loan facilities~~our products, and ~~government subsidies and credits.~~ ~~However, there can~~we expect our cash expenditures to continue to exceed receipts for the foreseeable future, as our revenues will not be ~~no assurance that our capital is~~ sufficient to ~~fund operations until such time as we begin to achieve positive cash flows. We have an effective shelf registration statement under which we could sell additional securities without advance notice.~~offset our operating expenses.

We ~~may~~will need to ~~raise~~increase revenues substantially beyond levels that we have attained in the past in order to generate sustainable operating profit and sufficient cash flows to continue doing business without raising additional capital ~~but~~from time to time. As a result of our expected operating losses and cash burn for the foreseeable future and recurring losses from operations, if we are unable to raise sufficient capital through additional debt or equity arrangements, there will be uncertainty regarding our ability to maintain liquidity sufficient to operate our business effectively, which raises substantial doubt as to our ability to continue as a going concern within one year from the date of issuance of these condensed consolidated financial statements. The condensed consolidated financial statements presented in Item 1 of this Report have been prepared assuming that we will continue as a going concern, and do not include any adjustments that might result from the outcome of this uncertainty. There can be no assurance that such ~~funding~~additional capital, whether in the form of debt or equity financing, will be sufficient or available and, if available, that such capital will be offered on terms and conditions acceptable to ~~us on favorable terms, if at all. The failure to raise capital when needed could have a material adverse effect on our business and financial condition.~~ us. We ~~may not be able to obtain~~are currently seeking additional financing ~~as needed on acceptable terms, or at all, which may require us~~in order to ~~reduce~~meet our ~~operating costs and other expenditures, including reductions of personnel, salaries and capital expenditures. Alternatively, or~~cash requirements for the foreseeable future. If the Company is unsuccessful in ~~addition to such potential measures, we may elect~~these efforts, it will need to implement ~~additional~~ cost reduction ~~actions as~~strategies, which could further affect

its near- and long-term business plan. These efforts may include, but are not limited to, reducing headcount and curtailing business activities. As further discussed in Note 11 to the condensed consolidated financial statements, in August 2022, we ~~may determine are necessary~~entered into an exclusive technology license and patent assignment agreement with Intel Corporation, under which we collected $3.1 million in ~~our best interests. Any such actions undertaken might limit our opportunities~~August 2022 and expect to ~~realize plans for revenue growth and we might not be able~~collect $0.4 million by early 2023. We expect this transaction to ~~reduce our costs~~result in ~~amounts sufficient to achieve break-even or profitable operations.~~a reduction of operating expenses of approximately $2.7 million on annual basis.

If we were to raise additional capital through sales of our equity securities, our stockholders would suffer dilution of their equity ownership. If we engage in debt financing, we may be required to accept terms that restrict our ability to incur additional indebtedness, prohibit us from paying dividends, repurchasing our stock or making investments, and force us to maintain specified liquidity or other ratios, any of which could harm our business, operating results and financial condition. If we need additional capital and cannot raise it on acceptable terms, we may not be able to, among other things:

Our failure to do any of these things could seriously harm our ability to execute our business strategy and may force us to curtail our existing ~~operations or R&D plans.~~operations.

We do not maintain any off-balance sheet arrangements or obligations that are reasonably likely to have a material current or future effect on our financial condition, results of operations, liquidity or capital resources.

See Note 1 to the condensed consolidated financial statements for a discussion of ~~recent~~recently-issued accounting ~~policies.~~pronouncements.

Disclosure Controls and Procedures. Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based on this evaluation, our management concluded that, as of ~~March 31,~~September 30, 2022, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting. During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

The discussion of legal matters in Note 46 of the Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this report under the heading “Legal Matters” is incorporated by reference in response to this Part II, Item 1.

We face many significant risks in our business, some of which are unknown to us and not presently foreseen. These risks could have a material adverse impact on our business, financial condition and results of operations in the future. ~~There~~Other than as set forth below, there have been no material changes with respect to the risk factors disclosed under Item 1A of our annual report on Form 10-K for the year ended December 31, 2021, which we filed with the SEC on March 31, 2022.

Our unaudited condensed consolidated financial statements as of September 30, 2022 have been prepared under the assumption that we will continue as a going concern for the next twelve months. As of September 30, 2022, we had cash, cash equivalents and investments of $3.9 million and an accumulated deficit of $135.0 million. We do not believe that our cash, cash equivalents and investments are sufficient to fund our operations for the next 12 months. We will need to increase revenues substantially beyond levels that we have attained in the past in order to generate sustainable operating profit and sufficient cash flows to continue doing business without raising additional capital from time to time. As a result of our expected operating losses and cash burn for the foreseeable future and recurring losses from operations, if we are unable to raise sufficient capital through additional debt or equity arrangements, there will be uncertainty regarding our ability to maintain liquidity sufficient to operate our business effectively, which raises substantial doubt as to our ability to continue as a going concern. If we cannot continue as a viable entity, our stockholders would likely lose most or all of their investment in us.

If we are unable to generate sustainable operating profit and sufficient cash flows, then our future success will depend on our ability to raise capital. We are seeking additional financing and evaluating financing alternatives in order to meet our cash requirements for the next 12 months. We cannot be certain that raising additional capital, whether through selling additional debt or equity securities or obtaining a line of credit or other loan, will be available to us or, if available, will be on terms acceptable to us. If we issue additional securities to raise funds, these securities may have rights, preferences, or privileges senior to those of our common stock, and our current stockholders may experience dilution. If we are unable to obtain funds when needed or on acceptable terms, we may be required to curtail our current product development programs, cut operating costs, forego future development and other opportunities or even terminate our operations.

We recorded net losses of approximately $17.8 million and $10.9 million for the nine months ended September 30, 2022 and year ended December 31, 2021, respectively. These and prior-year losses have resulted in significant negative cash flows. To remain competitive and expand our product offerings to customers, we will need to increase revenues substantially beyond levels that we have attained in the past in order to generate sustainable operating profit and sufficient cash flows to continue doing business without raising additional capital from time to time. Given our history of fluctuating revenues and operating losses, and the challenges we face in securing customers for our products, we cannot be certain that we will be able to achieve and maintain profitability on either a quarterly or annual basis in the future. As a result, we will need to raise additional capital to meet our cash requirements for the next 12 months, which may or may not be available to us at all or only on unfavorable terms.

We have significant accounts receivable from a significant customer and collectability is uncertain.

As of September 30, 2022, we had outstanding accounts receivable of $1.6 million, which included $0.7 million collectible from WeLink, a customer that represented 28% of our revenue for the nine months ended September 30, 2022. During the three months ended September 30, 2022, we had $1.1 million of product shipments to WeLink for which the revenue recognition criteria had not been met. Accordingly, we deferred the cost of net revenue of $0.6 million associated with these shipments. Historically, we have collected all amounts due from WeLink, although generally not within contractual payment terms. As of September 30, 2022, we determined that an allowance for doubtful accounts of $0.7 million was warranted on certain outstanding receivables from WeLink due to the collection delays. The longer collection times have negatively impacted our liquidity and working capital. No assurances can be given that we will be able to collect the receivables from WeLink in a timely manner, if at all. Recognition of additional bad debt expense, further delays in collecting accounts receivable or our inability to recognize the deferred cost of net revenues could have a material adverse effect on our financial condition, cash flows and results of operations

Russia’s recent military invasion of Ukraine has led to, and may lead to, additional sanctions being levied by the United States, European Union and other countries against Russia. Russia’s military invasion and the resulting sanctions have had an adverse effect on global markets. We cannot predict the progress or outcome of the situation in Ukraine, as the conflict and governmental reactions are rapidly developing and beyond our control. Prolonged unrest, intensified military activities, or more extensive sanctions impacting the region could have a material adverse effect on the global economy, and such effect could in turn have a material adverse effect on the operations, results of operations, financial condition, liquidity and business outlook of our business.

Sustained inflation could have a material adverse effect on our business, financial condition, results of operations and liquidity.

Inflation rates in the markets in which we operate have increased and may continue to rise. Inflation over the last several months has led us to experience higher costs, including higher labor costs, wafer and other costs for materials from suppliers, and transportation costs. Our suppliers have raised their prices and may continue to raise prices, and, although we have made minimal price increases thus far, in the competitive markets in which we operate, we may not be able to make corresponding price increases to preserve our gross margins and profitability. In addition, inflationary pressures could cause customers to delay or reduce purchases of our products or delay payments to us. If inflation rates continue to rise or remain elevated for a sustained period of time, they could have a material adverse effect on our business, financial condition, results of operations and liquidity.

If our goodwill or intangible assets become impaired, we would be required to record a charge to earnings.

We review our goodwill and intangible assets for impairment when events or changes in circumstances, such as a decline in our stock price and/or market capitalization, indicate the carrying value may not be recoverable. We test goodwill for impairment at least annually. If our goodwill or intangible assets are deemed to be impaired, an impairment loss equal to the amount by which the carrying amount exceeds the fair value of the assets would be recognized. We would be required to record an impairment charge in our financial statements during the period in which any impairment of our goodwill or intangible assets is determined, which would negatively affect our results of operations.

+ Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish copies of such omitted materials supplementally upon request by the SEC.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Delaware		77-0291941
(State or other jurisdiction		(I.R.S. Employer
of Incorporation or organization)		Identification Number)

PART I —	FINANCIAL INFORMATION	3

Item 1.	Financial Statements (Unaudited):	3

	Condensed Consolidated Balance Sheets as of ~~March 31,~~September 30, 2022 and December 31, 2021	3

	Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended ~~March 31,~~September 30, 2022 and 2021	4

	Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the three and nine months ended ~~March 31,~~September 30, 2022 and 2021	5

	Condensed Consolidated Statements of Cash Flows for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021	6

	Notes to Condensed Consolidated Financial Statements	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2226

Item 4.	Controls and Procedures	2834

PART II —	OTHER INFORMATION	2834

Item 1.	Legal Proceedings	2834

Item 1A.	Risk Factors	2834

Item 6.	Exhibits	2936

	Signatures	3037


Company share price (i)	$	4.21
Company common shares outstanding (ii)		8,716

Fair value of the Company's common shares outstanding		36,694

Fair value of the Company's warrants (iii)		301

Total fair value of the Company's share-based awards (iii)		782
Percent related to pre-combination service		80.76	%
Fair value of the Company's pre-combination service share-based awards (iii)		632

Consideration effectively transferred	$	37,627


(i) Represents the Company's share price as of December 16, 2021
(ii) Represents the Company's outstanding shares as of December 16, 2021
(iii) Represents the fair value of the Company's warrants outstanding and calculated as of December 16, 2021


	December 31,
	2021
Assets:	(in thousands)
Cash, cash equivalents and investments	$	19,064
Other current assets		2,558
Other assets		833
Intangibles
Developed technology		5,726
Customer relationships		2,556
		8,282
Goodwill		9,946
Liabilities:
Current liabilities		3,056
	$	37,627


	December 31,
	2021
Assets:	(in thousands)
Cash, cash equivalents and investments	$	19,064
Other current assets		2,558
Other assets		833
Intangibles
Developed technology		5,726
Customer relationships		2,556
		8,282
Goodwill		9,946
Liabilities:
Current liabilities		3,056
	$	37,627

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☐

	September 30, 2022
	Gross				Net
	Carrying		Accumulated		Carrying
	Amount		Amortization		Amount
Developed technology	$	5,726	$	1,133	$	4,593
Customer relationships		2,556		506		2,050
Other		186		26		160
Total	$	8,468	$	1,665	$	6,803


Year ending December 31,
2022	$	526
2023		2,099
2024		2,099
2025		2,011
2026		28
2027		10
Thereafter		30
	$	6,803

	As Reported		Adjustment			As Revised
Condensed Consolidated Statement of Operations:
Cost of net revenue	$	1,590	$	358		$	1,948
Gross profit		1,813		(358	)		1,455
Research and development		6,003		(517	)		5,486
Selling, general and administrative		2,546		159			2,705
Total operating expenses	$	8,549	$	(358	)	$	8,191


	Nine Months Ended
	September 30, 2022
Right-of-use assets:
Operating leases	$	957
Finance lease		224
Total right-of-use assets	$	1,181
Lease liabilities:
Operating leases	$	954
Finance lease		233
Total lease liabilities	$	1,187

	Operating
Year ending December 31,	leases
2022	$	292
2023		305
Total future lease payments		597
Less: imputed interest		(38	)
Present value of lease liabilities	$	559


Type	Number of Shares		Exercise Price		Expiration
Common stock		33	$	47.00	January 2023
Common stock		101	$	2.40	October 2023

	For the three months ended September 30,							For the nine months ended September 30,
Product category	2022		2021		change			2022		2021		change
Memory ICs	$	1,748	$	—	$	1,748		$	5,528	$	—	$	5,528
mmWave ICs		533		1,033		(500	)		1,699		2,651		(952	)
mmWave modules		779		292		487			3,139		292		2,847
mmWave other products		—		64		(64	)		18		73		(55	)
	$	3,060	$	1,389	$	1,671		$	10,384	$	3,016	$	7,368

(a)	Exhibits
	10.1*+	Technology License and Patent Assignment Agreement By and Between Intel Corporation and Peraso Inc. dated August 5, 2022
	31.1*	Rule 13a-14 certification
	31.2*	Rule 13a-14 certification
	32.1**	Section 1350 ~~certification~~certificationss
	101*	The following financial information from Peraso Inc.’s quarterly report on Form 10-Q for the period ended ~~March 31,~~September 30, 2022, filed with the SEC on ~~May 13,~~November 14, 2022, formatted in Inline Extensible Business Reporting Language (Inline XBRL): (i) the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the three and nine months ended ~~March 31,~~September 30, 2022 and 2021, (ii) the Condensed Consolidated Balance Sheets as of ~~March 31,~~September 30, 2022 and December 31, 2021, (iii) the Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the three and nine months ended ~~March 31,~~September 30, 2022 and 2021, (iv) the Condensed Consolidated Statements of Cash Flows for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, and (v) Notes to Condensed Consolidated Financial Statements.
	104*	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).


Dated: ~~May 13,~~November 14, 2022		PERASO INC.

	By:	/s/ Ronald Glibbery
		Ronald Glibbery
		Chief Executive Officer (Principal Executive Officer)

	By:	/s/ James W. Sullivan
		James W. Sullivan
		Chief Financial Officer
		(Principal Financial and Accounting Officer)